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Abstract 
Electrophysiological studies have recently suggested that influx of extra-cellular 
chloride through channels in the plasma membrane is important for the activation of 
mast cells by promoting the flow of extra-cellular calcium into the cytoplasm. In this 
study, the effects of chloride depletion and chloride channel blockers on mast cell 
activation were examined to evaluate if chloride ion was important for the influx of 
calcium. Purified rat peritoneal mast cells were chosen for the study. 
Antigen-stimulated histamine secretion from rat peritoneal mast cells and the related 
intracellular calcium increase were inhibited when extracellular chloride was 
replaced by either isethionate or gluconate anions. Such observations further 
supported the hypothesis that chloride ion influx modulated immunological 
activation of mast cells via a calcium dependent process. In contrast, removal of 
extracellular chloride had no effect on compound 48/80 activated mast cells either 
for histamine release or the intracellular calcium increase. This showed that the 
activation of chloride current was not essential for compound 48/80 stimulated 
exocytosis. Furthermore, chloride ion depletion experiments with ionophores and 
thapsigargin as mast cell stimulants produced more complicated results than could be 
explained by simple correlation of chloride ion depletion to calcium influx 
suppression. 
Given the potential role of chloride influx, it has been suggested that the mast cell 
stabilising action of the prototype compound DSCG is due to the prevention of 
calcium influx indirectly by blocking chloride channels. In order to evaluate this 
speculation pharmacologically, the effects of a range of chloride channel blockers 
including 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS), 4-acetamido-4'-
isothiocyanatostilbene-2,2‘-disulfonic acid(SITS), 5-nitro-2-(3-phenyl-propylamino)-
benzoic acid fNPPB), n-phenylanthranilic acid (DPC), flufenamic acid and 
indanyloxyacetic acid 94 (IAA-94) on histamine release and intracellular calcium 
increase from rat peritoneal mast cells were compared to the action of DSCG. 
Histamine release was employed as an indicator of mast cell activation which was 
induced either by specific activators such as anti-IgE, compound 48/80, calcium 
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ionophore A23187 and thapsigargin, or by the cytolytic detergent Triton X-100. All 
the chloride channel blockers tested were able to inhibit histamine release induced by 
all specific mast cell activators dose dependently ( 5 x 1 0 . 6 — 10"^  M). It was found 
that NPPB was most potent with IC50 values around lCT)M, whereas IAA-94 was 
almost ineffective. In contrast, histamine release induced by Triton X-100 was 
significantly potentiated by DIDS, SITS and fIufenamic acid. In conclusion, 
although chloride channel blockers tested could effectively inhibit mast cell 
activation by specific activators whose actions are dependent on calcium influx (anti-
IgE and compound 48/80), their similar potency in inhibiting histamine release 
induced by A23187, which directly transports extracellular-calcium into the 
cytoplasm, did not support the hypothesis that inhibition of chloride influx was their 
primary mast cell stabilising mechanism. Furthermore, the potentiation of the 
cytolytic release of histamine by Triton X-100 suggested that at the concentrations 
employed, these compounds may interfere with mast cell degranulation through non-
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Ca2+]i Intracellular calcium concentration 
A23187 Calcium ionophore A23187 
Ag Agonist 
B-cell B-lymphocyte 
BSA Bovine serum albumin 
cAMP Cyclic adenosine monophosphate 
CIF Calcium Influx Factor 
CTMC Connective tissue mast cell 
DAG 1,2-diacylglycerol 
DIDS 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid 
DOCC Depletion operated calcium channel 
DPC n-phenylanthranilic acid 
DSCG Disodium cromoglycate 
FcsRI High affinity IgE receptors 
G-protein Guanine nucleotide binding protein 
GTP-P-S Guanosine 5‘-0-2-thiodiphosphate 
GTP-y-S Guanosine 5 '-0-3 -thiotriphosphate 
IAA-94 Indanyloxyacetic acid 
IC50 Concentration producing 50% inhibition 
Icin A volume-activated chloride channel cloned 
from epithelial cells 
IcRAC Calcium release-activated calcium current 
IFN-y Interferon-y 
IgE Immunoglobulin E 
IL-3 Interleukin 3 
IL-4 Interleukin 4 
IP Inositol 4-monophosphate 
IP2 Inositol 1,4-bisphosphate 
IP3 Inositol 1,4,5-trisphosphate 
IP4 Inositol 1,3,4,5-tetrakisphosphate 
LT Leukotrienes 
M C j Tryptase containing human mast cell 
M C j c Tryptase & chymase containing human mast 
cell 
MMC Mucosal mast cell 
NPPB 5-nitro-2-(3-phenylpropylamino)-benzoic acid 
O V A Chicken egg ovalbumin 
PA Phosphatidic acid 




PIP2 Phosphatidylinositol 4,5-bisphosphate (PIP2) 
PKC Protein kinase C 
PLA2 Phospholipase A2 
PLC Phospholipase C 
PT Pertussis toxin 
RBL-2H3 Rat basophilic leukemia cells 
v i i 
RMCP-1 Rat mast cell protease 1 
RPMC Rat peritoneal mast cells 
SITS 4-acetamido-4'-isothiocyanatostilbene-2,2'-
disulfonic acid 
SMOCC Second messenger operated calcium channel 
T-cell T-lymphocyte 
TNF-a Tumour necrosis factor-a 
TX Thromboxanes 
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1.1. Historical Background 
In 1877, mast cells and basophils were first defined by Ehrlich on the basis of the 
metachromatic staining properties of their prominent cytoplasmic granules which is 
due to the presence of heparin, a sulphated glycosaminoglycan (Dvorak, 1989; 
Foreman, 1993a). He named these cells “Mastzellen” from the German word 
"masten", which means to fatten, or to feed because he viewed them as ‘fattened’ 
connective tissue cells. The other granular cell type was named “basophil，，and was 
discovered to circulate in the blood. Histamine, a potent vasoactive amine, is now 
known to be associated with mast cells due to the seminal observations of Riley and 
West (1953). Later, mast cells were noted for their capacity to release histamine as 
well as other inflammatory mediators, which have been implicated in airway 
constriction and bronchial spasm in human asthma. 
1.2. Origin and heterogeneity of mast cells 
Mast cells are the progeny of multipotential hematopoietic stem cells (Galli, 1993). 
The precursors of mast cells leave the bone marrow, invade connective or mucosal 
tissue, proliferate, and differentiate into mast cells (Rodewald et al., 1996). The 
development is regulated by T-cell and fibroblast derived growth factors (Kitamura 
et al., 1993a & b). Both T cell-dependent and fibroblast-dependent mechanisms are 
involved in the development of rodent mast cells, but only the fibroblast-dependent 
mechanism is involved in the development of human mast cells. The most important 
cytokine for the T cell-dependent mechanism appears to be interleukin-3, whereas for 
the fibroblast-dependent mechanism it appears to be the ligand for the c-kit receptor 
2 
(i.e. stem cell factor). Morphologically mature rat mast cells are large (9 to 13^m), 
with a single nucleus. and a cytoplasm packed with large membrane-bounded 
granules (Dvorak, 1991). 
Mast cell heterogeneity was first recognized in the rodent system by the early work 
of Enerback, who demonstrated variations in metachromatic staining properties of rat 
mast cells based on the type of fixation used (Enerback, 1966). Two different kinds 
of mast cells were identified: one is the mucosal mast cell (MMC) and the other is 
the connective tissue mast cell (CTMC). The proliferation of MMCs requires the T-
cell-derived cytokines interleukin 3 (IL-3) and IL-4 (Smith & Weis, 1996). 
Compared with the CTMC cell, the MMC contains fewer and smaller granules with a 
lower content of histamine and serotonin (Knudsen, 1995). Pharmacologically, the 
MMC is unresponsive to some secretagogues such as compound 48/80 which are 
effective on CTMC (Enerback, 1966). 
Compared with the rodent system, human mast cell heterogeneity is more complex. 
At least two types of mast cells were defined in the human. M C j cells were found to 
contain only one type of mast cell protease, tryptase, whereas M C ^ cells contained 
tryptase as well as chymase, cathepsin G, and human mast cell carboxypeptidase. 
M C j cells were found to predominate in the lung and small intestinal mucosa, 
whereas MC^c cells predominated in the skin and small intestinal submucosa. The 
relative abundance of M C j and M C ^ cells varies with tissue inflammation, such that 
the protease phenotype cannot be deduced solely on location alone. Therefore, the 
o 
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nomenclature of mucosal mast cells and connective tissue mast cells appeared 
inadequate in this system (Barrett & Pearce, 1993; Irani, 1997; Schwartz, 1987). 
Mast cell heterogeneity can also be defined on the basis of functional and 
pharmacological differences. Immunologic stimulation via the FceRI receptor and 
calcium ionophores activate all tissue-derived mast cells. However, non-
immunologic agonists show selectivity for mast cells isolated from various tissues. 
Agents such as substance P and the anaphylatoxins C5a and C3a cause histamine 
release from skin mast cells but not from lung mast cells. On the other hand, 
pharmacologic responsiveness of mast cells varies depending on the tissue source. 
For example, in the human, sodium cromoglycate and nedocromil are weak inhibitors 
of activation of lung-derived mast cells, but have no effect on mast cells from skin 
and intestine (Schulman et al., 1988). In rodents, it was found that cromoglycate and 
theophylline inhibited peptide-induced secretion from peritoneal mast cells but not 
from intestinal mucosal mast cells. In contrast, doxantrazole was effective against 
both types of rat mast cells. (Shanahan et al., 1986) 
1.3. Mast cell mediators 
Basically, mast cells play a critical role in immediate hypersensitivity reactions 
(Schwartz, 1994) due to the release of biologically active mediators. Typically, the 
mediators released from the mast cells can be classified into preformed and newly 
synthesized (Table 1) (Schwartz, 1987). The former includes biogenic amines (e.g. 
histamine), proteoglycans and neutral proteases. During activation, newly generated 
mediators consisting of arachidonic acid metabolites such as prostaglandins (PG) and 
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leukotrienes (LT), platelet-activating factor (PAF), and a variety of cytokines 
(Harvima & Schwartz, 1993; Marone, 1988; Schwartz, 1987) are produced. 
1.3.1. Preformed mediators 
The preformed mediators in secretory granules of mast cells are released into the 
surrounding tissues following mast cell activation. Histamine, derived from histidine, 
is the biogenic amine found in all known mast cells with direct potent vasoactive and 
smooth muscle spasmogenic effects (Bauza & Lagunoff, 1981). With degranulation, 
histamine bound to carboxyl and sulphate groups on proteins and proteoglycans, is 
released and dissociated from the proteoglycan: protein complex by cation exchange 
with extracellular sodium at neutral pH (Schwartz & Huff，1993). Released 
histamine is metabolized within minutes. In addition, serotonin, derived from 
tryptophan, is present in rodent connective tissue mast cells, but not in other mast 
cells. 
The presence of highly sulphated proteoglycans in secretory granules of mast cells 
confers the metachromatic staining properties of these cells. Two proteoglycans, 
heparin and chondroitin sulphate E, have been identified in human mast cells 
(Stevens et cd., 1988). These proteoglycans bind to histamine, neutral proteases, and 
acid hydrolases at the acidic pH inside mast cell secretory granules and may facilitate 
uptake and packaging of these preformed mediators. 
Neutral proteases are enzymes that catalyze the cleavage of peptide bonds and are the 
dominant protein components of secretory granules in human and rodent mast cells. 
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In addition, such enzymes also serve as selective markers that distinguish mast cells 
from other cell types and different types of mast cells (Irani & Schwartz, 1994; Irani, 
1997). MC^c cells contain tryptase together with chymase, cathepsin-G like protease, 
and mast cell carboxypeptidase while MCy cells contain tryptase, but lack the other 
neutral proteases present in MC^c cells. In rats, rat mast cell protease 1 (RMCP-1) in 
connective tissue mast cells and RMCP-2 in mucosal mast cells have been 
characterized. Compared to human mast cells, rat tryptase only localizes in a 
subpopulation of the connective tissue type of mast cell (Schwartz, 1994). The 
biological activities of tryptase include inactivation of fibrinogen, with subsequent 
anticoagulant effect. Chymase is a serine protease with chymotryptic-like activity 
(Schechter et al., 1983) and is bound to heparin, but remains stable after dissociation. 
1.3.2. Newly synthesized mediators 
These mediators are not preformed and can only be generated by mast cells upon 
appropriate stimulation. Unstimulated mast cells incorporate exogenous arachidonic 
acid into neutral lipids and phospholipids. Upon activation, hydrolysis of these lipids 
yields free arachidonate occurs through enzymatic pathways involving phospholipase 
八2, phospholipase C together with diacylglycerol lipase, and neutral lipid lipases. 
Arachidonic acid is further metabolized by two major enzymatic pathways (Fig 1.1). 
One is the cyclooxygenase pathway, which gives rise to prostaglandins (PG) and 
thromboxanes (TX). The other is the lipoxygenase pathway which gives rise to 
leukotrienes (LT) (Schwartz & Huff, 1993; Irani, 1997; Schwartz, 1987). The cyclo-
oxygenase enzyme, which is present in almost all tissues, efficiently converts 
arachidonic acid to a cyclic endoperoxide (PGHj). Then, the prostaglandins are 
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produced from PGH2 by further enzyme action. The prostaglandins act on specific 
cell surface receptors to, produce a range of biological effects. For the lipoxygenase 
pathway, the 5-lipoxygenase enzyme complex catalyses the breakdown of 
arachidonic acid to produce the epoxide LTA4, from which LTB4 and the 
peptidoleukotrienes LTC4, LTD4 and LTE4 are derived. 
Prostaglandin D: is the most important cyclooxygenase product of mast cells. It is a 
potent inhibitor of platelet aggregation (Mills & MacFarlane, 1974). Moreover, 
PGD2 exerts a variety ofbiologic actions in the eye including ocular hypotension and 
inflammatory effects on the conjunctiva. It causes increased conjunctival 
microvascular permeability, eosinophil infiltration and goblet cell depletion 
(Woodward et al., 1990). In addition, PGD� specifically reduced the proportion of 
macrophages that phagocytosed apoptotic cells to control the balance of apoptotic 
and necrotic leukocytes at inflamed foci (Rossi et al,, 1998). On the other hand, the 
lipoxygenase product most important to mast cells is LTC4. It is a potent 
bronchoconstrictor, enhances mucus production, increases vascular permeability, and 
acts on vascular smooth muscle (Lewis & Austen, 1984). The production of 
arachidonic acid metabolites begins within minutes of cell activation and lasts up to 
about 30 minutes. 
Upon activation, mast cells produce an array of cytokines, such as IL-3, IL-4, IL-5, 
IL-6, granulocyte macrophage-colony-stimulating factor, tumour necrosis factor-a 
(TNF-a) and interferon-y (IFN-y) (Okayama et al., 1995; Schwartz & Huff, 1993). 
They serve to activate endothelial cells to recruit eosinophils and other inflammatory 
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cells to the site of immediate hypersensitivity reactions, giving rise to the late phase 
of the allergic response, which sustains inflammation. 
1.4. Mast cell activation 
Mast cells can be activated by two mechanisms: the immunological pathway (also 
referred as antigenic pathway) and non-immunological pathway (also referred as 
non-antigenic pathway). Both pathways will result in the release of biologically 
active mediators which mediate the allergic response. Although the mechanism by 
which mast cell secretagogues bring about secretion is not yet completely known, 
several proposed mechanisms have been described. Only the immunological 
pathway is discussed here. Non-immunological pathways will be discussed in 
chapter 3. 
1.4.1. Antigenic /Immunologicalpathway 
The basis for the antigenic pathway is the production of IgE from B-lymphocytes. 
When a foreign allergen comes into contact with a susceptible individual, it leads to 
the stimulation o f B lymphocytes which induce B-cell differentiation to IgE antibody 
secreting cells and B-memory cells. The allergen also activates T-lymphocytes which 
can promote or inhibit IgE production via T-helper or T-suppressor cells respectively 
(Verecelli&Geha’ 1989). 
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The immunological activation of mast cells occurs through the interaction of 
multivalent antigen with antigen-specific IgE bound to high affinity IgE receptors 
(FcsRI) on the mast cell surface. The end result is the release of vasoactive mediators 
such as histamine and serotonin from cytoplasmic secretory granules (Ishizaka & 
Ishizaka, 1978). 
1.4.1.1. Aggregation of IgE Receptors (FcsRI) 
Unliganded FcsRI are monovalent and randomly distributed in the plasma 
membrane. It contains four polypeptide chains consisting of one a-chain, one p-chain 
and two y-chain subunits linked by disulphide bonds. Therefore, the receptor may be 
represented as otPy�. Radiolabeling studies suggest the a-chain is readily accessible at 
the cell-surface and contains the IgE binding site, whilst the p- and y2-chains may be 
buried within the plasma membrane and are important in FcsRI mediated signal 
transduction (Alber & Metzger，1993; Germano et al., 1984). The IgE-FcsRI receptor 
complex is free to move in the mast cell membrane. Once multivalent antigens bind 
to the IgE molecules, IgE cross-linking occurs and leads to the aggregation of FcsRI 
receptors (McCloskey, 1993). Aggregation of the high affinity IgE receptor 
molecules in the mast cell membrane initiates an intracellular signaling pathway that 
results in mast cell degranulation. However, the exact sequence of events which 
occur following receptor aggregation has yet to be determined. 
Currently, aggregation of IgE receptors involves the initiation of different 
biochemical events: a) tyrosine phosphorylation, b) activation of phospholipases and 
protein kinase C, and c) increase in intracellular calcium concentration which 
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results in degranulation (Cunha-Melo et al.’ 1987; Hamay et al., 1994; Sweiter et al., 
1995). Besides, current evidence shows that membrane permeabilities for calcium, 
chloride, sodium and potassium ions are important in the mast cell activation and 
specific ion channels have been identified in some cases. Intracellular 
mechanisms involving G proteins, intracellular calcium, cAMP and products of 
phosphoinositol breakdown are suggested to control these channels (Janisezewski et 
aL, 1992). 
1.4.1.2. Biochemical events following FcsRI aggregation 
Since FcsRI components on mast cells lack any known enzymatic activity, they must 
rely on associated molecules for signal transduction. During receptor purification, a 
tyrosine kinase that associates with the receptor has been identified (Siraganian, 
1993). Tyrosine chymase is activated immediately following dimerization of IgE 
receptors. This activation is possibly due to a conformational change in the 
extracellular domain of the receptor. Aggregation of FcsRI results in measurable 
increases in phosphorylation of many proteins in serine, threonine and tyrosine 
residues within 5-10 seconds (Scharenberg & Kinet, 1995). In addition, an isozyme 
of phospholipase C (PLC), PLCyl, (Park et al., 1991) and the y chain of FcsRI are 
rapidly tyrosine phosphorylated (Germano et al., 1984) resulting in PLC activation 
and PKC activation respectively. 
A great deal of evidence suggests that IgE receptor cross-linking results in the 
activation of a G-protein (Gomperts, 1983). The introduction of the nonhydrolysable 
analogues of GTP such as GTP-y-S into mast cells results in mast cell degranulation 
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and 1,2-diacylglycerol (DAG) formation (Neher, 1988; Sagi-Eisenberg, 1993). 
Moreover, this DAG production is inhibited by neomycin, an aminoglycoside 
antibiotic known to inhibit PI breakdown (Aridor et al., 1990). Thus based on these 
observations, other than the tyrosine kinase induced activation ofphospholipase C, a 
G-protein mediated activation of phospholipase C (Gp protein) may also be involved 
to cause degranulation in immunological mast cell activation. 
1.4.1.3. Ph osph olipase C activation 
Phosphatidylinositol metabolism is a universal signal-transduction mechanism 
activated by neurotransmitters, hormones and growth factors. A substantial amount 
of literature has showed that activation of cell-surface receptors ultimately linked to 
calcium mobilization requires the breakdown of phosphoinositides (Beaven et al., 
1984; Berridge & Irvine, 1989; Maeyama et al., 1988). The key enzyme in this 
process is the phosphatidylinositol 4,5-bisphosphate (PIP2)-hydr0lysing 
phospholipase C (PLC). Phospholipase C in mast cell activation is mainly involved 
in the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP�）which yields two 
intracellular second messengers: inositol 1,4,5-trisphosphate (IP3) and 1,2-
diacylglycerol (DAG). Activation ofPLC is via either tyrosine phosphorylation or G 
proteins (Beaven & Metzger, 1993). 
Inositol 1,4,5-trisphosphate (IP3) is the water-soluble product which, by binding to a 
specific receptor on the endoplasmic reticulum (Spat et cd,, 1986), releases Ca]+ from 
intracellular stores (Ferris et al., 1989; Streb et al., 1983) and leads to an increase in 
internal Ca"^ concentrations [Ca-^ ；. IP3 then undergoes further phosphorylation by 
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inositol 1,4,5-trisphosphate 3-kinase to produce inositol 1,3,4,5-tetrakisphosphate 
(IP4) (Connolly et al., 1987) which may regulate Ca�+ entry at the plasma membrane 
(Kuno & Gardner., 1987). IP4 can be dephosphorylated to yield another isomer of 
IP3, inositol 1,3,4-trisphosphate (Connolly et al., 1987). The l,4,5-IP3 isomer also 
undergoes a series of sequential dephosphorylations to form inositol 1,4-
bisphosphate (IP2), inositol 4-monophosphate (IP) and finally free inositol which is 
recycled to inositol phospholipids (Inhorn et al., 1987). 
DAG, the second product formed upon PIP2 hydrolysis, is known to activate protein 
kinase C (PKC) which can in turn cause protein phosphorylation (Sagi-Eisenburg, 
1993). Finally, DAG is metabolized either through its phosphorylation by a DAG 
kinase to form phosphatidic acid (PA) or by the action of a DAG lipase. In earlier 
studies, phosphatidylinositol breakdown to DAG was measured experimentally by 
analyzing the incorporation of radiolabelled precursors f^P] phosphate and [-¾" 
inositol. In rat mast cells, several reports have demonstrated that anti-IgE cause an 
accumulation of ["^ P^] phosphate into mast cell phosphatidylinositol, suggestive of 
increased activity of the phosphatidylinositol cycle. 
1.4.1.4. Phospholipc1seA2 activation 
Phospholipase A, (PLA,) is also activated following the aggregation of FcsRI 
(Bronner et al., 1990), therefore inducing the generation of free arachidonic acid that 
can be converted to various biologically active mediators via the cyclo-oxygenase 
and lipoxygenase pathways. Early studies demonstrated that exogenous arachidonic 
acid potentiated immunologically induced histamine release from rat peritoneal mast 
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cells and human basophils (Marone et al., 1979; Sullivan & Parker, 1979). 
Moreover, the involvement of PLA: in the generation of free arachidonic acid was 
supported by the inhibitory action of p-Bromophenacyl bromide, a PLA, inhibitor, on 
arachidonic acid liberation (Ishimoto et al., 1994). When rat peritoneal mast cells 
were treated with H-kDa-group-II-phospholipase-A^-specific inhibitors, histamine 
release from rat mast cells subjected to immunological stimulus such as antigen and 
non-immunological stimuli such as Ca"^ ionophore A23187, compound 48/80 and 
substance P was suppressed (Murakami et al., 1992). Furthermore, the inhibitory 
effect of biscoclaurine alkaloids including cepharanthine, berbamine, tetrandrine and 
isotetrandrine on phospholipase A2 activation in the signaling system of stimulated 
rat peritoneal mast cells suggests that PLA2 activation is probably through the 
uncoupling of a GTP-binding protein from the enzyme (Akiba et al., 1992). In 
addition, arachidonic acid along with IP3 induce the repetitive release of Ca�+ from 
the stores to maintain resting [Ca"^ ]； (Shuttleworth, 1997). 
IgE receptor cross-linking also appears to initiate phospholipid methylation involving 
the action of phospholipase A � . Phospholipid methylation has been suggested to be 
involved in signal transduction across membranes and has been associated with 
increases in membrane fluidity and promotion of transmembrane calcium fluxes 
(Benyon et al., 1986). Firstly, phosphatidylethanolamine (PE) is converted to 
phosphatidylcholine (PC) by the actions of two methyltransferases. 
Phosphatidylcholine is then further metabolised by phospholipase A2 to yield 
lysophosphatidylcholine and free arachidonic acid (Ishizaka et al., 1980 & 1983). 
Enhanced phospholipid methylation has been suggested to be an obligatory event in 
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activation-secretion coupling in mast cells by radiolabeling studies. The increase 
transfer of [-^-methyl] groups into cell lipids occurs rapidly following mast cells 
activated with concanvalin A, anti-IgE, C3a and C5a. However, recent studies have 
cast doubt on these reports of an increase in phospholipid methylation following 
activation of mast cells (Benyon et al., 1986). 
1.4.1.5. Adenylate cyclase activation 
It has been suggested that the lowered levels of cyclic adenosine monophosphate 
(cAMP) led to an increase in membrane permeability towards calcium and that an 
influx of such ions triggers the release mechanisms in mast cells (Alm & Bloom, 
1982). However, this concept is questioned by studies showing little correlation 
between histamine release and intracellular levels of cyclic nucleotides. 
In contrast, recent studies show that cAMP may play an important role in mast cell 
degranulation. The immunological activation of mast cells produces a transient 
increase in the intracellular level of cAMP (Winslow & Austen, 1982). Bridging of 
the IgE receptor molecules is found to activate adenylate cyclase via a G protein 
(Schwartz & Huff, 1993), followed by a rise in cAMP before mediator secretion. 
The intracellular effects of cAMP are mediated by the cAMP-dependent protein 
kinases which phosphorylate their respective protein substrates on serine/threonine 
residues (Siraganian, 1993). On the other hand, Penner et aL (1988) suggested that 
an increase of intracellular cAMP levels may be responsible for activating the 
chloride channel associated with I^ RAc activation. However, application of the cAMP 
phosphodiesterase, theophylline, can inhibit immunological mast cell mediator 
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release (Gomes, 1992). Hence, it was suggested that cAMP may provide a balance 
between mast cell activation and inhibition. However, the exact role of cAMP in 
histamine secretion is still unknown and debatable. 
1.4.1.6. Role of calcium 
It has long been known that Ca"" plays an important role in the process of exocytosis 
in mast cells. The early studies using the direct microinjection of Ca"^ into mast cells 
and application of calcium ionophore A23187 to elevate internal concentrations of 
Ca"^ evoked a secretory response (Foreman et al., 1973) which provided evidence for 
the key role of Ca"^ in mast cell degranulation. Using the calcium-sensitive 
fluorescent probe quin-2, a transient increase (20 sec.) in the intracellular free 
calcium followed by plateau phase of calcium influx in stimulated mast cells which 
were sensitized with monoclonal rat IgE antibody was determined (White et al., 
1984). In fact, elevation of intracellular calcium following FcsRI aggregation has 
been shown to depend upon 2 mechanisms: Ca"^ released by inositol-1,4,5-
triphosphate from intracellular store followed by influx of extracellular Ca�+ via a 
transmembrane pathway, through channels distinct from voltage-dependent calcium 
channels (Gericke et al., 1995; Penner et al., 1988; Zhang & McCloskey, 1995). 
Although mobilization of Ca"^  from stores in endoplasmic reticulum by IP3 and 
extracellular calcium influx principally account for the elevated [Ca"^ ],- which trigger 
mast cell secretion, the mechanism of this influx is open to speculation. Two 
hypotheses have been suggested to explain the calcium pool refilling process: 1) 
contact activation and 2) soluble messenger activation (Favre et al., 1996). 
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The first is the capacitative model which was first described by Putney in 1986. It 
stated that the binding of agonist (Ag) to a surface receptor can activate 
phospholipase C through G-protein, and then phospholipase C catalyzes the 
breakdown of phosphatidylinositol bisphosphate and release of IP3. Receptor-
generation of IP3 activates calcium channels in intracellular organelles where 
depletion of calcium occurs. Afterwards, a cytoplasmic signal is sent to the plasma 
membrane to activate depletion-operated calcium channels which mediate the 
calcium influx. Penner et al. (1988) reported that mast cell calcium influx is 
probably due to the influx of calcium through a calcium specific channel which was 
later identified to be responsible for IcRAc (Calcium release-activated calcium current) 
by Hoth & Penner (1992). The channel is voltage-independent and has a very low 
unitary conductance in fS range (Hoth, 1996). Moreover, this IcRAc specific channel 
is highly selective for Ca"+, over Ba]+ (Hoth, 1995)，Sr^  and Mn'+. This model is 
further supported by the discovery of Ca"^-ATPase inhibitors such as thapsigargin 
(Thastrup et al., 1990), calcium ionophores (ionomycin) (Hoth & Penner, 1992) and 
calcium chelator EGTA (Hoth & Penner, 1993) which can deplete intracellular 
calcium pools leading to the activation of a Ca:+ current. The capacitance model 
described by Putney links the depletion of internal calcium stores with the activation 
of a calcium influx pathway and the depletion of the intracellular calcium stores is 
believed to release a signal which activates this calcium influx. Randriamampita and 
Tsien (1993) described a Calcium Influx Factor (CIF) which was a small membrane 
permeable (<500D) phosphate-containing anion, and stimulated pool refilling. In 
addition to CIF, other factors have been reported to modulate Ca�+ influx induced by 
store depletion. It has been proposed that a small G-protein is involved in the signal 
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pathway linking empty stores to plasma membrane channels (Fasolato et al., 1994). 
Cytochrome P450 enzyme activity is also suggested in depletion-operated calcium 
channel regulation on the basis of calcium influx induced by various imidazole 
derivatives (Alvarez et aL, 1991). Recent studies suggest that the store-operated 
calcium channels may be encoded by the trp family of genes, which show structural 
homology to voltage-operated channels (Petersen, 1996). 
The second hypothesis explaining the calcium pool refilling process depends on the 
role of IP3. Under physiological conditions, mast cell degranulation is not simply a 
result of an increase in [Ca"^ ]；, but other second messenger systems: IP3 and IP4 in 
conjunction with calcium act synergistically in order to ensure fast and efficient 
secretion (>Mier, 1988; Penner & Neher, 1988). Irvine (1991 & 199¾ proposed that 
intracellular mobilization of Ca�+ is due to the action of IP3 and also suggested that 
IP4 controls Ca�+ entry into cells by binding to a receptor which interacts directly or 
indirectly with IP3 receptor in the endoplasmic reticulum. Evidence shows that IP. 
and its metabolite IP4 mediate calcium influx by the regulation of second messenger-
operated calcium channels. An IP3 induced Ca"^ influx is detected in whole cell 
recordings (Matthews et al., 1989b) to further support the dependence of second 
messenger on calcium influx. Also, IP4 mediated calcium entry by enhancing the 
activity of the Ca"^-permeable channel on plasma membrane (Lucldioff & Clapham, 
1992). IP3 can work alone or in combination with IP4 to promote calcium entry. 
Apart from lcRAc, the second of the reported cation channels was discovered to be a 
non-specific cation channel having a conductance of approximately 20-50pS 
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(Fasolato et al., 1993 & 1994; Matthews et al., 1989b; Penner et al., 1988). This non-
specific cation channel is believed to be regulated by a guanine nucleotide binding 
protein (G-protein) because it is activated by internal guanosine -5'-o-(-3-
thiotriphosphate) (GTP-y-S) and inhibited by internal guanosine 5,-o-(2-
thiodiphosphate) (GTP-P-S) (Matthews et al., 1989b). Although it is calcium 
permeable, it is not calcium selective (Felder et aL, 1994). More recently, Obukhov 
et al. (1995) have reported a large conductance (250pS) nonselective cation channel 
in RBL-2H3 cells. This channel was activated by ATP and carbachol and the 
activation was independent of internal calcium. 
1.5. Roles of chloride channels in mast cell activation 
From electro-physiological studies, chloride channels have been identified in rat 
peritoneal mast cells (Matthews et aL, 1989a) and RBL-2H3 cells (Romanin et aL, 
1991). A chloride current was detected upon activation of the cells by externally 
applied secretagogues or internally applied cyclic AMP and calcium. The effect of 
Ca2+ is slow and incomplete suggesting that the current is not due to Ca^^-activated 
Cr channels (Hoth et aL, 1993). There is also evidence for an indirect involvement 
of G-protein in the control of the current. This chloride current was speculated to 
drive the mast cell membrane potential more negative and hence a hyperpolarization 
driven calcium influx would be induced. The calcium influx activated was important 
for the sustained phase of elevated intracellular calcium during mast cell activation 
(Hoth et al., 1993). Besides, these chloride channels were sensitive to the blocking 
effects of chloride channel blockers (Romanin et al., 1991) such as DIDS and NPPB. 
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Furthermore, parallel inhibition of C1' channel activity and serotonin secretion is 
observed with either the C1" channel blocker 5-nitro-2-(3-phenylpropylamino) 
benzoic acid fNPPB) or the anti-allergic drug cromolyn in rat mucosal-type mast cell 
(line RBL-2H3) C^orris & Alton, 1996; Romanin et aL, 1991). Moreover, in another 
study (Dietrich & Lindau, 1994), the inhibitory effect o fDIDS on chloride channels 
in rat peritoneal mast cells was observed to be voltage and time dependent. Although 
extracellular DIDS inhibited exocytosis, substitution of extracellular chloride by 
glutamate has only very small effects on secretion stimulated with compound 48/80. 
Thus, the activation of the chloride current in mast cells is not essential for 
stimulation of exocytosis but may enhance secretion at suboptimal stimulation 
(Dietrich & Lindau, 1994). 
In order to evaluate the roles of extracellular chloride proposed by 
electrophysiological studies, Friis et al (1994) examined the effects of 
immunological activation on membrane permeability to chloride. Although they 
observed a large increase in the rate of chloride uptake into antigen stimulated mast 
cells (Friis et al.’ 1994), this chloride uptake was not directly related to histamine 
release, since the absence of extracellular calcium or the presence of DIDS inhibited 
antigen-induced histamine release without affecting the chloride uptake. Moreover, 
the Na7K+/2Cl. cotransport inhibitor, fmsemide abolished antigen-induced chloride 
uptake when added together with antigen but did not affect the histamine release. So, 
the occurrence of Na+/K+/2C1. cotransport was suggested. Nevertheless, the inward 
movement of chloride through chloride channels may be part of the mechanism 
controlling histamine secretion since removal of extracellular chloride or addition of 
19 
DIDS inhibits histamine secretion. It was also shown that antigen-induced histamine 
secretion was reduced when extracellular chloride was replaced with either 
isethionate or gluconate ions (Redrup et al., 1997). 
1.6. Aims of the study 
Although there are abundant electrophysiological studies proposing a modulatory 
role of Cr influx through plasma membrane chloride channel, pharmacological 
studies relating C1' influx to mediator release and intracellular calcium changes are 
rather limited. In order to further understand the relationship between chloride 
channels and mast cell activation, the current study first investigated how histamine 
release and intracellular calcium would be affected by chloride depletion from 
extracellular medium. Furthermore, since more recent studies suggested that DSCG 
may indirectly prevent the influx of calcium by blocking chloride channels fNorris & 
Alton, 1996), the effects of a selection of chloride channel blockers on mast cell 
activation were compared with DSCG. Based on the paper of Phipps et al. (1996), 
the chloride channel blockers selected for the current investigation include: 4,4，-
diisothiocyanostilbene-2,2 ‘ -disulfonic acid (DIDS), 4-acetamido-4'-
isothiocyanatostilbene-2,2'-disulfonic acid (SITS), 5-nitro-2-(3-phenylpropylamino)-
benzoic acid O^PPB), n-phenylanthranilic acid (DPC), flufenamic acid and 
indanyloxyacetic acid 94 (IAA-94). The effects of chloride depletion from 
extracellular medium and the chloride channel blockers on histamine release and 
calcium influx induced by secretagogues with different calcium mobilization profile 
were investigated. These secretagogues include anti-IgE, compound 48/80, calcium 
ionophore A23187 and thapsigargin. 
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Table 1. Mediators released by mast cells 
Mediators released by mast cells 
I. Preformed mediators 
Biogenic amines (histamine, serotonin in non-primates) 
Neutral proteases (tryptase, chymotryptic proteases) 
Proteoglycans (heparin, chondroitin sulfate) 
Acid hydrolase (p-hexosaminidase, P_glucuronidase) 
Chemotactic factors 
II. Newly generated 
Arachidonic acid products 
Leukotrienes (e.g. LTC4, LTD4, LTE4) 
Cycloxygenase products (e.g. PGD〕） 
Platelet activating factor 
///. Cytokines (growth and regulatory factors) 
Interleukins (IL-1, IL-3, IL-4, IL-5, IL-6) 
Inflammatory factors (TGF-p, TNF-a) 
Interferon-y 
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Fig 1.1 Biosynthetic pathway of prostaglandin (PG) and leukotriene (LT) production 
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Chapter 2 
MATERIALS AND METHODS 
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2.1. Materials 
The following compounds and materials were used in this study. Abbreviations used 
in later chapters are listed in brackets. 
2.1.1. Secretagogues Supplier 
Sheep Anti-Rat IgE (Anti-IgE) ICN Biomedicals Inc. 
Compound 48/80 Sigma Chemicals 
Calcium ionophore A23187 Sigma Chemicals 
Ionomycin Sigma Chemicals 
Thapsigargin Sigma Chemicals 
Triton X-100 Sigma Chemicals 
2.1.2. Anti-allergic compounds 
Theophylline Sigma Chemicals 
Disodium Cromoglycate (DSCG) Sigma Chemicals 
2.1.3. Chloride channel blockers 
Flufenamic acid Sigma Chemicals 
5-nitro-2-(3-phenylpropylamino)-benzoic acid fNPPB) RBI 
4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS) Sigma Chemicals 
4-acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid 
(SITS) Sigma Chemicals 
N-phenylanthranilic acid (DPC) RBI 
Indanyloxyacetic acid 94 (IAA-94) RBI 
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2.1.4. Materials for buffers 
Heparin Leo Pharmaceutical Product 
Bovine serum albumin (BSA) Sigma Chemicals 
Sodium Chloride (NaCl) Merck 
N-2-hydroxyethylpiperazine-N'-
2 ethanesuphonic acid (HEPES) Sigma Chemicals 
D-(+)-Glucose BDH 
Potassium chloride (KC1) BDH 
Sodium dihydrogen orthophosphate fNaH2PO4) BDH 
Calcium chloride solution (CaCl2) (lM) BDH 
Sodium gluconate (NaCeHnOy) Sigma Chemicals 
Potassium gluconate (KCeHnOy) Sigma Chemicals 
Calcium gluconate (Ca(C6H11O7)2) Sigma Chemicals 
Sodium isethionate (C2H5O4SNa) Sigma Chemicals 
2.1.5. Materials for rat sensitisation 
Aluminium hydroxide (Al(OH3)) Merck 
Adsorbed diphtheria, tetanus and pertussis toxin Pasteur Merieux 
Chicken egg albumin Grade V (OVA) Sigma Chemicals 
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2.1.6. Materials for histamine assay 
Sodium hydroxide P I^aOH) BDH 




Perchloric acid 70% Mallinckrodt 
Brij 35 solution Sigma Chemicals 
0-phthaldialdehyde (OPT) Sigma Chemicals 
Sulphuric acid Mallinckrodt 
Distilled water Dept. of Pharmacol, CUHK 
2.1.7. Materials for calcium measurement 
4)Calcium chloride DuPont NEN 
1 -Bromododecane oil Sigma Chemicals 
Fura-2 acetoxymethyl ester (am) Sigma Chemicals 
Fura-2 pentapotassium salt (free acid) Sigma Chemicals 
Liquid nitrogen Hong Kong Oxygen 
Scintillation fluid (Optiphase Hi-safe II) LKB Wallac 




Percoll Sigma Chemicals 
Trypan Blue BDH 
Alcian Blue BDH 
Dimethylsulphoxide (DMSO) Sigma Chemicals 
Polystyrene disposable tubes Sarstedt 
Polystyrene disposable cuvettes Sarstedt 
Polystyrene disposable sy 
Assorted magnetic stirrers Sigma Chemicals 
Eppendorf tubes Sarstedt 
1^ Eppendorf tubes Bio Plas Inc. USA 
Pasteur pipettes Elkay 
Cover glass Chance Propper Ltd. 
Scintillation vials Wheaton 
2 7 
2.2. Buffers 
The constituents for different buffers are listed below and they were dissolved in 
distilled or nanopure water. The pH was adjusted to 7.4 using NaOH. 
Ingredients 
(1) HEPES buffered Tyrode 137mM NaCl, 2.7mM KC1, 
(HEPES buffer) 0.4mM NaH2PO4.2H2O, 1 mM CaCl2, 
lOmM HEPES, 5.6mM Glucose 
(2) 10x Calcium free-HEPES buffer 10x concentration of all constituents in 
HEPES buffer but omitting CaCl2 
(3) Heparinised buffer HEPES buffer with 0.1ml heparin added 
per 50ml 
(4) BSA-HEPES buffer HEPES buffer with lmg/ml bovine 
serum albumin (BSA) was added 
(5) Calcium free-HEPES buffer HEPES buffer with the omission of 
CaCl2 
(6) Low Cr buffer G^a isethionate) 137mM C2H5O4SNa, 2.7mM KC1, 
(Isethionate buffer) 0.4mM NaH2PO4.2H2O, lmM CaCl2, 
lOmM HEPES, 5.6mM Glucose 
28 
(7) Ca2+ free isethionate buffer Isethionate buffer with the 
• omission of CaCl2 
(8) Cr free buffer Q a^. gluconate) 137mM NaC6HnO7, 2.7mM 
(Gluconate buffer) K C6H"O7, 0.4mM N a H 2 P O 4 . 2 H 2 O , 
lmM Ca(C6H11O7)2, lOmM HEPES, 
5.6mM Glucose 
2+ 
(9) Ca free gluconate buffer Gluconate buffer with the 
omission of Ca(C6H11O7)2 
(10) Phosphate buffered saline 2.68mM KC1, 1.47mM KH2PO4, 
137mM NaCl, 8.09mM NaH2PO4, 
pH=7.2 
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2.3. Stock solutions of drugs 
Anti-rat IgE was obtained in lyophilised form. It was solubilised in distilled water 
(2ml) and aliquoted into micro-centrifuge tubes. Ionophore A23187 and ionomycin 
were dissolved in 100% DMSO and aliquoted at a stock concentration of 2mM 
(40^il) and lmM (40 i^l) respectively. Thapsigargin was also dissolved in 100% 
DMSO at a stock concentration of l .5mM. All of these stock solutions were stored at 
-20°C until required. Compound 48/80 was initially solubilised in distilled water 
(lmg/ml) before dilution using the appropriate buffer and was kept at 4 � C for two 
weeks. 
DIDS and SITS were prepared freshly by dissolving in appropriate buffer at a stock 
concentration of lmg/ml. NPPB, flufenamic acid, IAA-94 were all dissolved in 
100% DMSO at a stock concentration of 500mM. DPC was dissolved in 100% 
ethanol at a stock concentration of 200mM. After serial dilution using buffer, the 
final concentration ofDMSO or ethanol in the experiment tubes was less than 0.1%. 
Fura 2-AM was dissolved in 100% DMSO at a stock concentration of lmM and was 
aliquoted into Eppendorf tubes. The stock solution was covered by aluminium foil 
and stored at —20°C until required. 
All other compounds used were dissolved in buffer. 
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2.4. Source of mast ceils 
Most studies on mast cells were performed on mast cells isolated from the rat 
peritoneal fluid because these cells are relatively easy to isolate (Dvorak, 1991; 
Uvnas, 1992). Moreover, they can also be purified in one single step. Hence, rat 
peritoneal mast cells provide a convenient source of mast cells that allows important 
preliminary investigation to proceed before other sources of mast cells are tested. 
2.4.1. Animals 
Rat peritoneal mast cells were obtained from male Sprague Dawley rats which were 
supplied by the Laboratory Animal Services Centre (LASEC) of the Chinese 
University ofHong Kong. 
2.4.2. Sensitization of animals 
The rats (body weight 200-250g) were sensitised with a 0.6ml intraperitoneal 
injection from a mixture containing 80mg ovalbumin, 1.2g Al(OH)3, and 1ml 
Pertussis toxin in 5ml PBS (O.OlM). The injection solution was mixed throughoutly 
by continual stirring for half an hour before use. After injection, the rats were kept in 
the animal house for three to six weeks for the development of immunological 
response before use. 
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2.4.3. Isolation ofrat peritoneal mast cells 
The rats were anaesthetized with diethyl ether and sacrificed by cervical dislocation 
followed by exsanguination under running water. The fur in the peritoneal region 
was removed and 20ml of heparinised buffer was injected intraperitoneally. The 
abdomen was gently massaged for 2 minutes and was cut open along the midline. A 
disposable plastic Pasteur pipette was used to collect the peritoneal fluid to 
polystyrene centrifuge tubes which were kept on ice. Peritoneal cells that were 
heavily contaminated with blood were discarded. The cells were pelleted by 
centrifugation (190xg, 4 � C , 5 min.). 
2.4.4. Purification of rat peritoneal mast cells 
The cells were pelleted as above and resuspended in BSA-HEPES buffer. The mixed 
cell suspension was then washed once more by centrifugation and resuspended in 
1ml of BSA-HEPES buffer. A percoll solution (4ml) containing 9 parts of percoll 
and 1 part of 10x calcium free-HEPES buffer was mixed with the cells (Mackay and 
Pearce, 1992). 1ml of BSA-HEPES buffer was carefully layered on top of the 
percoll-cell suspension. The cells were then purified through the percoll density 
gradient by centrifugation (150xg, 4°C, 25 min.). After purification, the purified rat 
peritoneal mast cells were concentrated at the bottom of the tube while other cell 
types were suspended between the percoll and the 1ml BSA-HEPES buffer layer on 
top. The supernatant was therefore aspirated, leaving the pure mast cell suspension in 
the bottom of the tube. The cells were washed once using BSA-HEPES buffer and 
twice in HEPES buffer by centrifligation (190g, 4 � C , 5 min.) to remove the 
remaining percoll. For those experiments in the absence of extracellular calcium, 
mast cells were washed in calcium free HEPES buffer. 
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2.4.5. Cell counting 
Total mast cell number and purity was assessed by staining with alcian blue (1% 
alcian blue in 0.9% NaCl containing 0.5M HC1 and 1% v/v Tween 20). An aliquot of 
the rat peritoneal mast cells was mixed with the dye in the ratio of 9:1 and incubated 
for 5 minutes at 37°C to allow the cells to take up the dye. Only granules of mast 
cells took up the dye and stained in blue colour. 
Cell viability was assessed by the trypan blue exclusion test. An aliquot of the rat 
peritoneal mast cells was mixed with the dye (0.4%) in the ratio 1:1 and incubated 
for 10 minutes at 37°C to allow the cells to take up the dye. Only dead cells took up 
the dye and stained in blue colour. 
Stained cells were then counted in a Neubaur haemocytometer (Fig. 2.1). lO i^l of 
dye loaded cells were added to the haemocytometer under a glass coverslip. The 
number of stained or unstained cells were counted and calculated as follows: 
No. ofcells/ml 二 average number of cells per square x dilution factor x 10^ 
A percentage of stained or unstained cells can be calculated and mast cell purity was 
determined by comparing the number of stained cells to the total number of cells 
counted. Over 95% purity and viability of mast cells were required for experiments. 
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Fig. 2.1 The standard hemocytometer chamber. The circle indicates the approximate 
area covered at 100x microscope magnification (lOx ocukr and 10x objective). Include 
ceUs oa top and left touching middle Une (0). Do not count ceUs touching middle Une at 
bottom aad right (0 ) . Count 4 corner squares and the middle square in the chamber. 
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2.5. General protocol for histamine release 
For investigating the effect of chloride depletion, isolated mast cells were 
resuspended in 450 i^l of appropriate buffer and prewarmed for 10 minutes at 37°C in 
water bath before the addition of 50 i^l of 10x secretagogues. For the investigation of 
chloride channel blockers, 250|il of the purified mast cells after 10 minutes 
equilibration at 37°C in HEPES buffer were added to 225^il of the test compounds. 
Then 25^1 of the secretagogue was added after the required pre-incubation time. 
After 10 minutes, the reaction was terminated by the addition of 1ml ice cold buffer, 
followed by centrifugation (190xg, 4 � C , 5min). The supernatants were decanted into 
test tubes and 1.5ml of distilled water was added to the cell pellet tubes. Cell pellet 
solutions were either boiled for 15 minutes at 80°C (manual histamine assay) or 
treated with 70% v/v perchloric acid (automated assay) to release residual histamine. 
The samples were frozen at -20°C until the determination ofhistamine contents. 
Secretagogues including anti-IgE, compound 48/80, calcium ionophore A23187, 
ionomycin and triton X-100 were added as described above. However, thapsigargin 
was required to incubate with the purified mast cells for 10 minutes in calcium free-
HEPES or calcium free-isethionate/gluconate buffer before the addition of CaCl2 or 
calcium gluconate in order to obtain optimum histamine release. Finally, the 
reaction was terminated after 10 minutes as described before. 
2.6. Histamine assay 
The principle of the histamine assay was first described by Shore et al (1959). 
Histamine reacts with o-phthaldialdehyde (OPT) under alkaline conditions to form a 
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fluorescent condensation product (Fig.2.2). This product is stabilised by acidification 
and the fluorescence is measured using a spectrophotometer at an excitation 
wavelength of360nm and an emission wavelength of 450nm. Detected fluorescence 
is directly proportional to histamine concentration in the original sample. 
Manual assay 
Each sample (1.5ml) was first treated with 200|Lil of 1 M NaOH and was mixed using 
a vortex mixer. Then lOO i^l of OPT (lmg/ml in methanol) was added to each sample 
and was immediately mixed by vortexing and allowed to react for 4 minutes. The 
reaction was terminated by the addition of lOO i^l of 3M HC1 followed by vortexing. 
The samples were centrifuged (3900xg, 2 5 � C , 25min) and the fluorescence was 
measured in an Hitachi F-4010 fluorescence spectrophotometer at the specified 
wavelengths mentioned before. 
Automated assay 
Some peritoneal mast cell samples containing drugs which interfered with the 
fluorescence detection were assayed on an autoanalyser. The automated assay 
chemically extracted histamine from the sample before the condensation reaction 
with OPT and hence eliminated any interference with the fluorescence detection. 
Dmgs that interfered with the manual assay ofhistamine include the chloride channel 
blockers. 
Each 1.5ml sample was first treated with 75^il of70% perchloric acid to free residual 
histamine from cell pellet tubes and to precipitate proteins in the sample. After 
vortex mixing, the samples were centrifuged (3900xg, 8 � C , 20min) to precipitate the 
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protein or any cell debris. The samples were then assayed by a Bran+Lubbe Auto 
Analyser II (Atkinson et al., 1979). Briefly, samples were first made alkaline and the 
histamine was extracted into salt-saturated butanol. After the separation of aqueous 
and organic phase, heptane was added to make the organic phase less polar and the 
histamine was then back-extracted into dilute HC1. The amine extracted was reacted 
with OPT under alkaline conditions and the product was stabilised by acidification. 
The fluorescence detected was recorded on a computer using a software (AACE) 
which was supplied by the manufacturer. 
Calculation 
Histamine release was expressed as a percentage of the total amount of the amine 
originally present in the cells. Thus: 
% Histamine release = [HS / (HS+HC)] xlOO% 
where HS is the amount ofhistamine in the supernatant and HC is the corresponding 
histamine content of the cell pellet. In all experiments, values are corrected for the 
spontaneous histamine release which occurred in buffer alone. 
The inhibition of histamine release was expressed in terms of the percentage 
inhibition of the control release induced by a secretagogue in the absence of any 
inhibitor. Thus: 
% Inhibition = [(CR-IR) / CR] x 100% 
where CR is the control release and IR is the release in the presence ofthe inhibitor. 
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Fig. 2.2 Condensation reaction ofhistamine and o-phthaldialdehyde 
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2.7. Protocol for fura-2 fluorescence measurement of intracellular 
calcium 
2.7.1. Fura-2 cell loading 
lC)6 cells/ml ofPercoll purified rat peritoneal mast cells were prepared as described in 
section 2.4. The cells were loaded with 1 i^M of fura-2 A M in BSA-HEPES buffer 
for 20 minutes at 3 7 � C with occasional agitation. The cell suspension was diluted 3 
fold using prewarmed BSA-HEPES buffer and was left for 5 to 10 minutes at 37°C 
for the complete hydrolysis of the ester to free acid. The dye-loaded cells were then 
washed by centrifugation (12000xg, 30sec, 25°C) for two to three times in 
appropriate buffers. Following resuspension in 500 i^l of buffer, the cells were kept 
at 4°C and were used within 90 minutes to reduce leakage of the dye. 
2.7.2. Fura-2 fluorescence measurement by fluorescence microscope 
In the study, the MiraCa/ PRO ratio imaging system from Life Science (Fig 2.3) was 
used to measure fura-2 fluorescence. MiraCa/ PRO uses the SpectraMASTER 
monochromatic illuminator which output wavelength can be continuously varied 
between 300 and 900nm with full control of the bandwidth between 1 and 30nm. 
Fluorescence image through a Leica inverted fluorescence microscope were then 
captured by MiraCa/ PRO supplied with a high resolution integrating video camera 
supporting a resolution of up to 768 x 576 pixels. The captured images were stored 
on the computer hard disc of the MimCal PRO Windows 95 based system control 
processor and processed with according to the Grynkiewicz equation. Data may 
easily be exchanged between Windows applications for analysis before output. 
39 
For cell observation, stainless-steel coverslip holder was greased with high vacuum 
silicone grease to stop leakage from the resulting chamber. A single coverslip was 
placed in the metal holder and 5 i^l of fura-2 loaded cell suspension was added to the 
centre of the slip. 500^1 of prewarmed experimental buffer was then added to the 
chamber after 60 seconds. The chamber was kept at a constant temperature of 3 7 � C 
by a heater. The cells in the chamber were excited by wavelengths of 340 and 
380nm to make up a single ratiometric data point. Bright field light was used to 
focus the image. 500 i^l of 2x secretagogue in appropriate buffer was added and 
fluorescence reading at 340:380 was recorded every 0.8 second for 5 minutes at the 
emission wavelength of 510nm. Background fluorescence at both wavelengths were 
grabbed after the experiment by moving to an area devoid of cells and all subsequent 
readings were automatically corrected for these background readings in subsequent 
calculations. (Fig. 2.4) 
Secretagogues including anti-IgE, compound 48/80 and ionomycin were added as 
described above. However, thapsigargin was required to incubate with the mast cell 
droplet for 10 minutes in 500|^ 1 of appropriate buffer without calcium in the 3 7 � C 
chamber. Then 500 i^l o f 2 x CdCh or calcium gluconate was added and fluorescence 
reading at 340:380 was recorded as described above. 
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2.73, Calculation of intracellular calcium 
The intracellular calcium was automatically calculated by the software using the 
Grynkiewicz equation (Grynkiewicz et al., 1984): 
[Ca 2+] = Kd P ( R-Rmin) / (Rmax-R) 
where Kd = The dissociation constant for the dye (224nM at 37°C for fura-2) 
R = The ratio offluorescence (F340/F380) read at510nm emission wavelength 
Rmin 二 The ratio of fluorescence when the dye is completely free of Ca 2+ 
Rmax = The ratio of fluorescence when the dye is saturated with Ca �+ 
3 = The ratio of saturated to free fluorescence at 380nm excitation 
(Fsat / Ffree at 380nm excitation) 
Results were expressed as the increase in free intracellular calcium (nM). 
Calibration for determining the values ofRmin, Rmax and p was performed by using 
fura-2 free acid solutions. 
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Fig 2.3 A schematic ofatypical imaging system showing the major components in the light path 
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Fig. 2.4 The ratio image of fiira-2 loaded cells was recorded after grabbing the 
background fluorescence. 
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2.8. Protocol for ^^a^^ influx measurement 
The following method for measuring ^^a^^ influx was modified from Foreman et al, 
(1977). Rat peritoneal mast cells were isolated and purified as described in section 
2.4. After the final wash, cells were resuspended at a concentration of 1.5xl0^ 
cells/ml in HEPES buffer and were equilibrated at 3 7 � C for 10 minutes. Micro-
Eppendorf tubes were prepared by adding 100^1 of 1-bromododecane oil to the 
bottom of each tube. All reactions were performed in Sarstedt tubes in triplicate 
before transferring to the micro-Eppendorf tubes. 100^1 of the purified mast cells 
were added to 1C%1 of the test compounds or buffer in polystyrene tubes. After 10 
minutes, lOO i^l ofbuffer containing 40Kbq ^^C^^ with or without secretagogues was 
added. The reaction was terminated 10 minutes later by transferring 300^1 of the 
reaction mixture to ^-Eppendorf tubes containing lOO i^l of 1-bromododecane oil and 
the cells were separated from free '^Ca^^ in the aqueous phase by centrifugation 
(12000xg, lmin, 25°C ). The tubes were immediately frozen in liquid nitrogen and 
the tips containing the cell pellets were cut off. The tube bottoms were placed in 
scintillation vials containing 2ml of 1% Triton X-100 and were left overnight to lyse 
the cells. 5ml of scintillant was added to each vial, followed by shaking and the 
disintegrations per minute was counted in a Beckman scintillation counter (5 minutes 
per sample). 
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2.9. Measurement of^^a^^ influx 
Blanks were counted with each experiment and the mean of the blanks was 
subtracted from each count. The spontaneous '^Ca^^ count is the influx of^^a '^ in 
the absence ofany secretagogue. The mean of the counts from the spontaneous tubes 
was subtracted from each sample count. Results were expressed as the percentage of 
control. 
2.10. Statistical analysis 
Results are expressed as means 土 SEM. Statistical analysis is performed using the 









The mobilization of Ca�+ from stores in endoplasmic reticulum by IP3 and 
extracellular calcium influx principally account for the elevated [Ca]+]; which 
triggers IgE mediated mast cell secretion. From the electrophysiological studies of 
Matthews et al. (1989a), it was suggested that a driving force for the entry ofexternal 
calcium may be due to the chloride influx through plasma membrane chloride 
channels and consequently caused a negative membrane potential following 
stimulation. Moreover, it was found that a small-conductance chloride channel was 
activated in rat peritoneal mast cells when they were stimulated with externally 
applied secretagogues (Matthews et al, 1989a). 
From pharmacological studies, it was shown that there was a fast and large increase 
in the rate of chloride uptake into antigen stimulated mast cells (Friis et al., 1994). It 
was suggested that the inward movement of chloride through chloride channels 
might be part of the mechanism controlling histamine secretion since removal of 
extracellular chloride by either isethionate or gluconate anions inhibited antigen-
stimulated histamine secretion (Friis et al., 1994 & Redmp et al., 1997) and the 
maximal extent of secretion in permeabilized mast cells elicited by calcium plus 
guanosine-5 '-0-(3-thiotriphosphate) (Churcher & Gomperts, 1990). Due to the 
effectiveness of fmsemide in inhibiting the chloride influx, the occurrence of 
Na+/K+/2Cr contransporter was also suggested to account for the fast chloride 
uptake. 
In this study, we attempted to confirm and elucidate the chloride influx effect on 
mast cell activation by studying the effect of chloride depletion in mast cells 
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activated by different secretagogues which activate mast cells through different 
pathways. The extracellular chloride was replaced by either isethionate or gluconate 
anions and full HEPES buffer was included for comparison. Both histamine release 
and free intracellular calcium increase in mast cells activated in different chloride 
free buffers were measured. 
3. L1 Mechanism of non-immunological stimuli 
In contrast to the immunological pathway, non-immunological stimuli utilize a 
secretory pathway different from IgE dependent stimuli. This pathway of mast cell 
activation can be cytotoxic or non-cytotoxic. The cytotoxic compounds, such as the 
detergent TritonX-100 (Holowka & Baird, 1996; Johnson & Moran, 1970), act by 
disrupting the plasma membrane, causing irreversible damage and expulsion of the 
cellular contents. The non-cytotoxic compounds, such as polybasic agents, peptides, 
anaphylatoxins, thapsigargin and calcium ionophores, cause the activation of the 
mast cell, resulting in the release of mediators but without causing the irreversible 
damage associated with the cytotoxic compounds. It is known that different 
histamine-releasing agents can trigger histamine release from mast cells through 
different mechanisms. 
Many basic compounds, including a large number of drugs, can release histamine 
from mast cells. A role for sialic acid residues (negatively charged endings of 
membrane glycolipids and glycoproteins) on the cell surface (Mousli et al., 1989) 
and G-protein activation (Aridor et al.’ 1990; Mousli et al., 1991, 1992, 1994 & 
1995) have been proposed in this activation pathway. However, the exact 
biochemistry of this pathway is still unclear. Compound 48/80, the best known 
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polybasic histamine releaser, is a mixed polymer of phenethylamine cross-linked by 
formaldehyde (Foreman, 1993b; Lagunoff et cd., 1983). Pertussis toxin which 
interferes with some G-proteins (Gi) via ADP-ribosylation inhibited histamine 
release induced by compound 48/80, substance P, mastoparan, neuropeptide Y, 
bradykinin and spermine showing that a G-protein sensitive to pertussis toxin was 
involved in the non-immunological histamine release (Bronner et al., 1990; 
Nakamura & Ui, 1984, 1985; Mousli et al., 1989, 1991, 1994 & 1995). Moreover, 
pretreatment of mast cells with neuraminidase decreased the secretagogic effect of 
substance P, mastoparan, bradykinin and compound 48/80 indicating the 
involvement of sialic acid residues in the initial binding of stimuli to mast cells, 
which activates G-proteins and allows the increase in PLC activity to induce 
exocytosis (Mousli etal., 1989; Bueb et aL, 1990). 
Since both compound 48/80 and anti-IgE induce mast cell degranulation by causing 
the production of IP3 which subsequently cause a transient increase of the free 
intracellular calcium concentration, it appears that both compounds show some 
similar mast cell activation pathways. The difference between these two mast cell 
activation pathways is the dependence of extracellular calcium. Actually, the 
requirement for the influx of extracellular calcium is obligatory for antigen-
stimulated exocytosis (Sagi-Eisenberg, 1993). In contrast, compound 48/80 can 
produce a significant sub-maximal level of histamine release even in the absence of 
extracellular calcium (Kuno et al., 1990) although the maximum level of histamine 
release is obtained only in the presence of extracellular calcium. 
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Clearly, the introduction of calcium ionophores (A23187 and ionomycin) 
demonstrates the initiation of mast cell secretory activity by elevation of cytoplasmic 
Ca2+ levels (Lagunoff et al., 1983). A23187 seems to act by transporting calcium 
into the cell and thereby initiating a reaction which results in the secretion of 
histamine. The action of which depends on the presence of calcium within a specific 
concentration range (Foreman et al., 1973). Calcium ionophore A23187 induced a 
rapid increase in cytoplasmic Ca^^ in rat mast cells and subsequent histamine release 
in quin-2 fluorescence measurement (White et al., 1984). Therefore, ionophores 
which increase the calcium influx through cell membranes would be useful for the 
investigation ofphysiological processes. 
Thapsigargin, a Ca^^-ATPase inhibitor of the endoplasmic reticulum, prevents 
reuptake of Ca�+ in the endoplasmic reticulum subsequently leading to influx of 
extracellular Ca:+ and elevation of [Ca^ ]^i (Thastrup et al., 1990; Treiman et al., 
1998). Over the past ten years, this compound has become a popular tool in studies 
directed at elucidating the mechanisms of intracellular Ca〕+ signalling. The action of 
thapsigargin on rat mast cells is known to activate histamine release by a mechanism 
very sensitive to the action of protein kinase C, as concluded from the synergism 
observed with the phorbol ester 12-0-tetra-decanoylphorbol-13-acetate (TPA) 
(Alfonso et al., 1994). 
3.2. Materials and methods 
The materials and methods used are described in chapter 2. The HEPES, isethionate 
and gluconate buffers were prepared using nanopure water. Moreover, the 
osmolarity of each buffer was measured by Vapour Pressure Osmometer in order to 
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eliminate any result relating to osmotic stresses. The measured osmolarities are 
shown in table 3.1. Since the values were comparable at around 290 mmol/L which 
lay within the acceptable range, the buffers could be used to perform various 
experiments. The purified rat peritoneal mast cells were collected as usual and 
resuspended in HEPES, isethionate or gluconate buffers. Cells were then 
equilibrated in each buffer for 10 minutes at 37°C. For histamine release experiment, 
450^il of equilibrated cells were added to test tubes containing 50^1 of 10x 
secretagogues. The incubation with various secreted proceeded for 10 minutes. 
Results are expressed as mean 土 S E M and are corrected for the spontaneous 
histamine release. For the measurement of intracellular calcium, 500^1 of the 
appropriate prewarmed buffer was added to 5^ il ofequilibrated cell droplet. 500^il of 
2x secretagogue was then added to cells in the calcium experiment after starting 
recording for around 70 second to establish the base line. Finally, results are 
quantitatively expressed as the area under the curve (AUC) of the calcium increase 
vs time plots. 
3.3. Results 
3.3丄 Effects ofanti-IgE induced histamine release in chloridefree buffers 
After purification, the spontaneous histamine release of rat peritoneal mast cells is 
<15 % oftotal cellular histamine in all three buffer treatments. In order to study the 
effects ofchloride depletion on mast cell activation, purified rat peritoneal mast cells 
were equilibrated in the three buffers, i.e. HEPES, isethionate and gluconate buffers 
at 37。C for 10 minutes before challenging with secretagogues. Results demonstrated 
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that anti-IgE dose dependently induced histamine release from cells incubated in 
H E P E S and isethionate buffers (Fig. 3.1). For H E P E S buffer, the histamine release 
was from 8.0±2.0 % to 40.0土2.8 % over the anti-IgE dilution range of 1/3000 to 
1/100. For isethionate buffer, the histamine release was from 1.0土1.5 % to 28.0±3.2 
o/o. The anti-IgE induced response was almost abolished in gluconate buffer over the 
anti-IgE concentration range tested. The maximum histamine release is only 4.0土1.7 
o/o for gluconate buffer. It is obvious that the histamine releasing effect of anti-IgE 
was significantly reduced in both chloride free buffers. 
3丄2. Effects of compound 48/80 induced histamine release in chloride free 
buffers 
In all three buffers, compound 48/80 induced comparable dose dependent histamine 
release from purified rat peritoneal mast cells. About 2.0 % to 60.0 % histamine 
release was induced by compound 48/80 using a concentration range from 0.05 to 0.5 
|ig/ml (Fig. 3.2). The overall dose response curves for the two C1' free buffers were 
not significantly different from that o f H E P E S buffer. However, maximum level of 
histamine release was significantly reduced in the gluconate buffer. At 0.5 ^ ig/ml of 
compound 48/80, 67.0±1.6 % ofhistamine release in H E P E S buffer was reduced to 
57.9±2.3o/o in the gluconate buffer. Moreover, the release with gluconate buffer is 
significantly higher than the release with the other two buffers at 0.1 jug/ml 
compound 48/80 and the release in isethionate buffer is significantly higher than 
H E P E S buffer pound 48/80 concentrations 0.15 and 0.2 ^ ig/ml. 
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3.3.3. Effects of calcium ionophore A23187 induced histamine release in chloride 
free buffers 
As with compound 48/80, purified rat peritoneal mast cells also exhibited a dose 
dependent histamine release induced by calcium ionophore A23187 in the three 
different buffers. About 10.0 % to 60.0 % histamine release was obtained over 0.03 
to 0.6 ^iM calcium ionophore A23187 concentration range in the three buffer 
treatments (Fig. 3.3). However, the A23187 induced histamine release in gluconate 
buffer is only significantly reduced at ionophore concentrations of0.1 and 0.3 |uM. 
3.3.4. Effects of ionomycin induced histamine release in chloride free buffers 
In contrast to calcium ionophore A23187, a different pattern was showed in 
ionomycin induced histamine release dose response curves in the three buffer 
treatments (Fig. 3.4). For H E P E S buffer, cells exhibited a dose dependent histamine 
release from 4.0±1.6 % to 72.0±1.1 % over 0.125 to 1 ^ iM ionomycin concentration 
range. Although the dose response was reduced in both types of C1' free buffers 
when compared controls at certain ionomycin concentrations, the reduction of 
histamine release was greater in gluconate buffer. The maximum histamine release 
induced by 1 ^ iM ionomycin was decreased to 59.0±6.0 % in isethionate buffer and 
52±1.5 % in gluconate buffer. 
3.3.5. Effects ofthapsigargin induced histamine release in chloridefree buffers 
Purified rat peritoneal mast cells exhibited a dose dependent histamine release 
induced by thapsigargin in all three buffer treatments (Fig. 3.5). It was found that 
0.1±1.1 % to 45.8±2.6 % histamine release was induced by 1.25 to 12.5 n M 
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thapsigargin in H E P E S buffer. Comparing to H E P E S buffer, the histamine releasing 
effects of low concentrations of thapsigargin seemed to have increased in the 
isethionate buffer. In contrast, the histamine releasing activity of thapsigargin was 
generally decreased in gluconate buffer. The response at 12.5 n M thapsigargin was 
significantly decreased to 21.3±3.2 % histamine release in gluconate buffer. 
3.3.6. Effects ofTriton-X100 induced histamine release in chloridefree buffers 
T w o concentrations of triton-X 100 (0.045 i^l/rnl and 0.065 p,l/ml) were chosen to 
compare the affect of the three different buffers on cytotoxic non-immunologically 
induced histamine release. The lower concentration of triton-X 100 induced 
20.0±0.9 % histamine release in H E P E S buffer whereas the higher concentration 
induced 66.7+2.4 % histamine release. The histamine release in both C1" free 
buffers was similar to that in H E P E S buffer (Fig. 3.6). 
3.3.7. Effects of anti-IgE on the free intracellular calcium concentration of rat 
peritoneal mast cells in chloridefree buffers 
The change in free intracellular calcium concentration in purified rat peritoneal mast 
cells was observed under a fluorescence microscope. The basal intracellular calcium 
concentration [Ca^ ]^j recorded in this study was about 30 to 100 n M which is 
comparable to the basal [Ca^^]j of 100 n M reported by Siraganian (1993). Fig. 3.7 
showed the typical changes in a single mast cell and obvious colour changes can be 
seen after the addition of anti-IgE (1/200). A biphasic calcium response was 
observed from the immunologically activated rat peritoneal mast cells. A rapid and 
transient rise (0-75sec after anti-IgE addition) followed by a sustained plateau phase 
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was observed. A m o n g individual mast cells from the same experiment, calcium 
increases in both phases showed heterogeneity in amplitude and frequency (Fig. 3.8) 
Before statistical analysis, all readings were corrected for the resting [Ca�+]!. In a 
single experiment, readings from 20 individual cells were averaged for further 
analysis (Fig. 3.9). Both the transient peak and plateau phase were found to be 
suppressed in both C1' free buffer treatments from a single experiment as illustrated 
in fig. 3.9. Furthermore, the onset of the initial peaks was significantly delayed in 
the C r free buffers. Although the initial transient peak became less obvious after 
taking an average of the total experiments done (Fig. 3.10), the suppression of 
calcium response in both C1' free buffer treatments was still obvious. The sustained 
plateau peak level was reduced from 151.6±38.4 n M in H E P E S buffer to 116.4±29.2 
n M in isethionate buffer and 59.3+28.5 n M in gluconate buffer. 
To achieve a quantitative comparison of the effects ofcalcium influx on activated rat 
peritoneal mast cells in different buffer treatments, the area under the curve (AUC) 
ofthe calcium increase vs time plots were calculated as suggested by Narenjkar et al. 
(1998). In the present study, the A U C values were calculated by using the Prism 
curve analysing software. Since the transient calcium peak in individual cells 
occurred within the range of 0-75 sec after anti-IgE addition, the area under the curve 
within this time range of the averaged readings from 20 cells in each experiment was 
calculated and then averaged for quantitative comparison. Similarly, the sustained 
plateau phase (75sec after anti-IgE addition to the end of the experiment) and the 
whole time course of anti-IgE induced increase in [Ca^^]j in rat peritoneal mast cells 
were also analysed (Table 3.2). The A U C values oftransient peak in H E P E S buffer, 
isethionate and gluconate buffers were 12,684.1+3,745.8, 7,582.6±2,688.4 and 
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3,564.4±919.9 nMsec respectively. Hence the calcium influx of the transient peak 
region induced by anti-IgE was reduced by 44.74+6.9 % and 70.10+2.9 % in 
isethionate and gluconate buffer respectively (Table 3.3). Moreover, the A U C 
values of plateau phase in HEPES, isethionate and gluconate buffers were 
13,777.3±2,353.9, 9,629.0±1,701.1 and 5,960.0±1,245.6 nMsec respectively while 
the total A U C values of the three buffer treatments were 26,938.6+3,897.6, 
17,640.0±3,174.7 and 9,817.0±1,616.3 nMsec respectively. So the calcium influx of 
the plateau phase was reduced by 28.5土6.7 % and 57.1±4.9 % in isethionate and 
gluconate buffer respectively while the total calcium influx induced by anti-IgE was 
reduced by 36.2±5.9% and 64.0±2.6% in isethionate and gluconate buffer 
respectively. In other words, the calcium influx was reduced or inhibited in the 
absence ofextracellular chloride for immunological activation. 
3丄8. Effects ofcompound 48/80 on thefree intracellular calcium concentration 
ofratperitoneal mast cells in chloridefree buffers 
The patterns obtained with compound 48/80 (0.15 ^ig/ml) induced increase in the 
free intracellular calcium concentration in the three buffers were different from that 
of anti-IgE. A monophasic calcium response was observed (Fig. 3.11). Moreover, 
the sustained plateau part (75sec after compound 48/80 addition to the end of 
experiment) following the transient peak (0-75 sec after compound 48/80 addition) 
was much lower. It can be seen in the pseudo-colour pictures recorded in Fig. 3.11 
that the periods of obvious colour change were restricted to the second row 
corresponding to the transient peak of calcium influx. N o conspicuous difference 
was seen among the three buffer treatments. By looking at the effect of compound 
48/80 activated individual mast cells from the same experiment, the response 
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behaved homogeneously in terms of shape, frequency and rate of change of [Ca^^]j 
(Fig. 3.12). After taking the average of 20 individual mast cells from a single 
experiment in the three buffer treatments, the pattern of free intracellular calcium 
increase in both C1' free buffers was similar to that in H E P E S buffer but had a slower 
onset (Fig. 3.13). The pattern was similar after grouping all the experiments done 
(Fig. 3.14). The transient peak levels in H E P E S buffer, isethionate and gluconate 
buffers were 131.4±33.1, 111.7+15.4 and 91.9±10.5 n M respectively while the 
plateau peak levels were 54.2±1.8, 38.3+4.6 and 34.3±3.3 n M respectively. 
For quantitative analysis, the A U C values of transient peak (0-75 sec after compound 
48/80 addition) in H E P E S buffer, isethionate and gluconate buffers were 
9,385.3±1,017.5, 8,113.2+484.2 and 8,195.2±82L6 nMsec respectively (Table 3.2). 
In the same order, the A U C values of the plateau phase in the three buffers were 
6,190.3土516.9, 4,621.0±569.9 and 3,572.3±363.4 nMsec respectively while the total 
A U C values ofthe three buffer treatments were 15,890.0+972.1, 13,166.7+938.7 and 
12,084.5±923.1 nMsec respectively. Hence the calcium increase induced by 
compound 48/80 in transient peak was reduced by 8.2土11.4 % and 10.0+9.7 % in 
isethionate and gluconate buffers respectively (Table 3.3). Moreover, the calcium 
influx of the plateau phase in the two C1" free buffers was reduced by 25.2±7.1 % 
and 42.2±3.7 % respectively while the total calcium influx was reduced by 15.7土7.7 
o/o and 23.3±6.1 % in the two C1" free buffers respectively. It was obvious that the 
A U C of transient peak in both C1' free buffers was not significantly different from 
that o f H E P E S buffer. Hence, the significant suppression oftotal A U C in gluconate 
buffer was mainly due to the reduction ofthe A U C of the plateau phase in both CF 
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free buffers. The calcium influx was hence only marginally affected when compared 
to that in anti-IgE activation. 
J.J.9. Effects ofionomycin on thefree intracellular calcium concentration ofrat 
peritoneal mast cells in chloride free buffers 
The pattern of calcium increase in mast cells activated by 0.5 ^iM of ionomycin in 
the three buffer treatments was different from those induced by anti-IgE or 
compound 48/80. N o transient peak was observed. Instead, the curve increased 
gradually to the maximum level and then stabilised at this level for up to 5 minutes. 
Fig. 3.15 showed a typical change on calcium influx in single mast cells and the 
obvious difference can be seen after the addition of ionomycin. By looking at the 
effect of ionomycin activated individual mast cells from the same experiment, the 
response behaved homogeneously in terms of shape, frequency and rate of change of 
Ca2+]i (Fig. 3.16). After taking the average of reading from 20 mast cells from the 
same experiment and comparing the effects of the three buffer treatments on cells 
from the same population, the calcium responses were found to be suppressed in both 
C1 free buffers (Fig. 3.17). The suppression remained obvious after grouping the 
data from all the experiments done. It was found that the maximum calcium increase 
level in H E P E S buffer was 220.3±29.8 n M and the value was decreased to 
141.8±19.6 n M in isethionate buffer and 84.3±9.6 n M in gluconate buffer (Fig. 
3.18). 
Since no transient peak was observed in ionomycin activated rat peritoneal mast 
cells, only the total area under the curves of the whole time course was calculated for 
58 
further quantitative analysis. From table 3.2, the total A U C values were 
15,890.0±972.1, 13,166.7±938.7 and 12,084.5±923.1 nMsec for HEPES, isethionate 
and gluconate buffers respectively. Significant decrease in calcium influx signal is 
observed in both types of C1' free buffers. The total A U C in H E P E S buffer was 
reduced by 25.1+5.0 % and 56.0+5.0% in the isethionate and gluconate buffers 
respectively (Table 3.3). Thus, the calcium influx on ionomycin activated mast cells 
was significantly reduced in the absence of extracellular chloride. 
3.3.10. Effects of thapsigargin on the free intracellular calcium concentration of 
rat peritoneal mast cells in chloride free buffers 
The pattern of calcium increase in mast cell activated by thapsigargin (O.Ol^M) in 
the three buffer treatments was similar to that induced by ionomycin (Fig. 3.19). 
Once again, no initial transient peak was observed. Moreover, the response behaved 
homogeneously in terms of shape, frequency and rate of change of [Ca^^]i when 
comparing individual mast cells activated by thapsigargin from the same experiment 
(Fig. 3.20). After taking the average of reading from 20 mast cells and comparing the 
effects of the three buffer treatments, the calcium response was found to be 
suppressed in both C1" free buffer treatments (Fig. 3.21). The suppression again 
remained obvious after grouping data from all the experiments done. It was found 
that the maximum calcium increase level in H E P E S buffer was 383.4土13.4 n M and 
the value was decreased to 207.9+36.2 n M in isethionate buffer and 90.2±18.2 n M in 
gluconate buffer (Fig. 3.22). 
For quantitative analysis, the total A U C o f H E P E S buffer, isethionate and gluconate 
buffer treatments was 79,197.5±10,952.9, 46,060.0+7,033.1 and 18,170.0±3,483.8 
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nMsec respectively (Table 3.2). It was obvious that the calcium influx signal was 
significantly suppressed in both types of C1" free buffers. The total A U C in H E P E S 
buffer was reduced by 41.1±6.8 % and 75.0土7.6 % in the isethionate and gluconate 
buffers respectively (Table 3.3). Thus, the calcium influx on thapsigargin activated 
mast cells was also significantly reduced in the absence of extracellular chloride. 
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Table 3.1. The osmolarity ofthe three buffers used (n=5) 
Buffer ~ M a j o r chloride related components~~~~Osmolarity~~ 
(mmol/L) 
(1)HEPES buffer 1 3 7 m M NaCl, 2.7mM KC1, l m M CaCl2 292.8 ± 0 . 7 ^ 
(2) Isethionate buffer 1 3 7 m M NaSC2H5O4, 2.7mM KC1, 289.0± 1.1 ~ ~ 
l m M CaCl2 
(3) Gluconate buffer 1 3 7 m M NaC6H,1O7, 2.7mM KCeHnOy, 286.0 + 0.7~~ 
l m M Ca(QsH11O7)2 
61 
Table 3.2. Area under the curve (AUC) values for the transient peak region, the 
sustained plateau phase region and the whole Ca�+ increase-time curve on the 
calcium influx in rat peritoneal mast cells activated by different secretagogues in the 
three buffer treatments. Values are mean 土 S E M for n experiments. * 二 p<0.05, 
when compared with values obtained in H E P E S buffer. 
Anti-rat IgE Compound 48/80 Ionomycin Thapsigargin 
(1/200) (0.15^igmr') (0.5^iM) (O.Ol^M) 
(n=7) (n=6) (n=8) (n=4) 
Transient peak area 
(nMsec) 
HEPES buffer 12684+3745 9385+1017 
Isethionate buffer 7582+2688* 8113+484 
Gluconate buffer 3564+919* 8195+821 
Plateau phase area 
(nMsec) 
HEPES buffer 13777+2353 6190+516 
Isethionate buffer 9629土1701* 4621土569* 
Gluconate buffer 5960+1245* 3572+363* 
Total area 
(nMsec) 
HEPES buffer 26938+3897 15890+972 44296+3536 79197+10952 
Isethionate buffer 17640+3174* 13166+938 33341+3533* 46060+7033* 
Gluconate buffer 9817+1616* 12084+923* 18951+2078* 18170+3483* 
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Table 3.3. % of the A U C values obtained in H E P E S buffer for the transient peak 
region, the sustained plateau phase and the total Ca"" increase-time curve which were 
reduced when mast cells were activated by different secretagogues in the two C1' free 
buffer treatments. Values are mean 土 SEN4 for n experiments. 
% of inhibition = (AUC in HEPES buffer-AUC in C1' free buffer) / A U C in HEPES buffer x 100% 
Anti-rat IgE C o m p o u n d Ionomyc in Thaps iga rg in 
48/80 
(n=7) (n-6) (n-8) (n=4) 
% of inhibition in 
transient peak 
I s e t h i o n a t e b u f f e r 4 4 . 8土6 . 9 8 .2二11 .4 
G l u c o n a t e b u t T e r 7 0 . 1 : 2 . 9 1 0 . 0 + 9 . 7 
% of inhibition in 
plateau phase 
I s e t h i o n a t e bu tTer 2 8 . 5 - 6 . 7 2 5 . 2 : 7 . 1 
G l u c o n a t e b u f f e r 5 7 . 1 + 4 . 9 4 2 . 2 + 3 . 7 
% of inhibition in 
total area 
I s e t h i o n a t e b u f f e r 36 .2二5 .9 15.7二7.7 2 5 . K 5 . 0 4 1 .卜 6 . 8 
G l u c o m i t e b u f f e r 6 4 . 0 - 2 . 6 23 .3二6.1 56.()二5.0 75 .0二7 .6 
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Fig. 3.1. Anti-rat IgE induced histamine release from R P M C in H E P E S and chloride 
free buffers. Mast cells were equilibrated for 10 minutes at 37。C in relevant buffers 
before the addition ofanti-rat IgE. Spontaneous histamine release is <15% of total 
cellular histamine for all three treatments. Results are expressed as mean 土 S E M for 
n = 4. • = p<0.05 against HEPES buffer. 
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Fig. 3.2. Compound 48/80 induced histamine release from R P M C in H E P E S and 
chloride free buffers. Mast cells were equilibrated for 10 minutes at 37°C in relevant 
buffers before the addition of compound 48/80. Spontaneous histamine release is 
<150/0 of total cellular histamine for all three treatments. Results are expressed as 
mean 土 S E M for n=4-8. * = p<0.05 against H E P E S buffer. 
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Fig- 3.3. Calcium ionophore A23187 induced histamine release from R P M C in 
H E P E S and chloride free buffers. Mast cells were equilibrated for 10 minutes at 
37°C in relevant buffers before the addition of calcium ionophore A23187. 
Spontaneous histamine release is <15% of total cellular histamine for all three 
treatments. Results are expressed as mean 土 S E M for n=5. * = p<0.05 against 
H E P E S buffer. 
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Fig. 3.4. Ionomycin induced histamine release from R P M C in H E P E S and chloride 
free buffers. Mast cells were equilibrated for 10 minutes at 37°C in relevant buffers 
before the addition of ionomycin. Spontaneous histamine release is < 1 5 % of total 
cellular histamine for all three treatments. Results are expressed as mean 土 S E M for 
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Fig. 3.5. Thapsigargin induced histamine release from R P M C in H E P E S and chloride 
free buffers. Mast cells were equilibrated for 10 minutes at 37°C in relevant calcium 
free buffers before the addition of thapsigargin. Calcium was added after the 10 
minutes incubation of cells and thapsigargin. Spontaneous histamine release is 
<15% of total cellular histamine for all three treatments. Results are expressed as 
mean 土 S E M for n=5. * 二 p<0.05 against H E P E S buffer. 
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Fig. 3.6. Triton-X induced histamine release from R P M C in H E P E S and chloride 
free buffers. Mast cells were equilibrated for 10 minutes at 37。C in relevant buffers 
before the addition of triton-X. Spontaneous histamine release is <15% of total 
cellular histamine for all three treatments. Results are expressed as mean 土 S E M for 
n-4. 
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Fig. 3.7. Typical pattern showing the changes in calcium influx of single rat peritoneal 
mast cell from the same population of cells activated by secretagogue anti-IgE (1/200 
dilution) under the fluorescence microscope in different buffers (Top: H E P E S buffer; 
Middle: Isethionate buffer; Bottom: Gluconate buffer). The left-hand side showed the 
pseudo-color conversion of the fluorescence changes ofthe cell and the right-hand side 
showed the intensity plots of the intracellular calcium changes with time. 70 
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Fig. 3.8. The effects of anti-rat IgE (1/200) on the free intracellular calcium 
concentration in individual fura-2 loaded rat peritoneal mast cells in H E P E S buffer from 
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Fig. 3.9. Typical example showing the effects of anti-rat IgE (1/200) on the free 
intracellular calcium concentration in fura-2 loaded rat peritoneal mast cells 
incubating in different buffers. The result of each curve is the average of20 regions 
(i.e. 20 cells) from the same experiment. 
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Fig. 3.10. The averaged effects of anti-rat IgE (1/200) on the free intracellular 
calcium concentration in fura-2 loaded rat peritoneal mast cells incubating in 
different buffers. Values are mean for 7 experiments, error bars are omitted for 
clarity. 
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Fig. 3.11. Typical pattem showing the changes in calcium influx of single rat peritoneal 
mast cell from the same population of cells activated by secretagogue compound 48/80 
(0.15^ig/ml) under the fluorescence microscope in different buffers (Top: H E P E S buffer; 
Middle: Isethionate buffer; Bottom: Gluconate buffer). The left-hand side showed the 
pseudo-color conversion of the fluorescence changes ofthe cell and the right-hand side 
showed the intensity plots of the intracellular calcium changes with time. 
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Fig. 3.12. The effects of compound 48/80 (0.15^igAnl) on the free intracellular calcium 
concentration in individual fura-2 loaded rat peritoneal mast cells in H E P E S buffer from 
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Fig. 3.13. Typical example showing the effects of compound 48/80 (0.15^g/ml) on 
the free intracellular calcium concentration in fura-2 loaded rat peritoneal mast cells 
incubating in different buffers. The result ofeach curve is the average of 20 regions 
(i.e. 20 cells) from the same experiment. 
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Fig. 3.14. The averaged effects of compound 48/80 (0.15jiig/ml) on the free 
intracellular calcium concentration in fura-2 loaded rat peritoneal mast cells 
incubating in different buffers. Values are mean for 6 experiments, error bars are 
omitted for clarity. 
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Fig. 3.15. Typical pattem showing the changes in calcium influx of single rat peritoneal 
mast cell from the same population of cells activated by secretagogue ionomycin 
(0.5^iM) under the fluorescence microscope in different buffers (Top: H E P E S bufFer; 
Middle: Isethionate buffer; Bottom: Gluconate buffer). The left-hand side showed the 
pseudo-color conversion of the fluorescence changes of the cell and the right-hand side 
showed the intensity plots of the intracellular calcium changes with time. 
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Fig. 3.16. The effects of ionomycin (0.5^iM) on the free intracellular calcium 
concentration in individual fura-2 loaded rat peritoneal mast cells in H E P E S buffer from 
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Fig. 3.17. Typical example showing the effects of ionomycin (0.5^iM) on the free 
intracellular calcium concentration in fura-2 loaded rat peritoneal mast cells 
incubating in different buffers. The result of each curve is the average of20 regions 
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Fig. 3.18. The averaged effects of ionomycin (0.5^iM) on the free intracellular 
calcium concentration in fura-2 loaded rat peritoneal mast cells incubating in 
different buffers. Values are mean for 8 experiments, error bars are omitted for 
clarity. 
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Fig. 3.19. Typical pattem showing the changes in calcium influx ofsingle rat peritoneal 
mast cell from the same population of cells activated by secretagogue thapsigargin 
(O.Ol^iM) under the fluorescence microscope in different buffers (Top: H E P E S buffer; 
Middle: Isethionate buffer; Bottom: Gluconate buffer). The left-hand side showed the 
pseudo-color conversion of the fluorescence changes ofthe cell and the right-hand side 
showed the intensity plots of the intracellular calcium changes with time. 
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Fig. 3.20. The effects of thapsigargin (O.Olp,M) on the free intracellular calcium 
concentration in individual fura-2 loaded rat peritoneal mast cells in H E P E S buffer from 
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Fig. 3.21. Typical example showing the effects of thapsigargin (O.Ol^M) on the free 
intracellular calcium concentration in fura-2 loaded rat peritoneal mast cells 
incubating in different buffers. The result of each curve is the average of 20 regions 
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Fig. 3.22. The averaged effects of thapsigargin (O.Ol^iM) on the free intracellular 
calcium concentration in fura-2 loaded rat peritoneal mast cells incubating in 




In order to confirm and elucidate that the inward movement of chloride through 
chloride channels may be part of the mechanism controlling antigen-stimulated 
histamine secretion from rat peritoneal mast cells as previously reported. (Friis et al., 
1994), mast cells were activated in the current study in buffers in which extracellular 
chloride ions were replaced by either isethionate or gluconate anions. The chloride 
ions were only partly removed by isethionate anions (other remaining in the form of 
2 . 7 m M K C 1 and l m M CaCl2) in the isethionate buffer while all chloride ions were 
replaced in the gluconate buffer. Apart from the immunological activation, the 
influence of chloride depletion in non-immunological activation of mast cells was 
also studied using secretagogues such as compound 48/80, calcium ionophore 
A23187, ionomycin, thapsigargin and triton X-100. 
Early observations showed that immunological mast cell degranulation was due to 
the increase of free intracellular calcium concentration (White et al., 1984). 
Moreover, there was a rapid rise of intracellular calcium that peaked and then fell to 
a sustained but lower elevated level. It had been suggested that this transient 
increase in the free intracellular calcium was mainly due to the release of calcium 
from the intracellular stores, following the action of IP3 on these stores (Berridge & 
Irvine，1989). The later sustained elevation of calcium was due to an influx of 
calcium across the plasma membrane, through channels distinct from voltage-
dependent calcium channels (Penner et al., 1988). In the case of anti-IgE, the 
transient increase in calcium is insufficient to initiate complete exocytosis but is 
essential for activating processes which eventually lead to the influx of extracellular 
calcium which is obligatory for anti-IgE induced exocytosis. 
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Various calcium entry pathways have been suggested to be responsible for the 
voltage independent calcium influx in non-excitable cells (Putney, 1986). In mast 
cells, influx of calcium was believed to be through the second messenger operated 
calcium channel, S M O C C and the depletion operated calcium channel, D O C C 
(Favre et a/.,1996; Felder et al,, 1994). A calcium-specific channel responsible for 
ICRAC (calcium release-activated calcium current) which may correspond to the 
D O C C reported above was suggested (Penner et al., 1988). This current is not 
voltage-activated and has a very low unitary conductance in the fS range (Hoth, 
1996). Moreover, it is found that IcRAC is highly selective for Ca]+ ions over Ba〕+ 
(Hoth, 1995), Sr2+ and Mn〕+ using patch-clamp and fura-2 measurements (Hoth & 
Penner, 1992). This channel is believed to be activated by the depletion of calcium 
from intracellular stores, and was thought to be the main mechanism of secretagogue 
induced calcium entry. Later, it was reported that IcRAc was activated following the 
activation of a chloride channel which hyperpolarized the mast cells and allowed the 
subsequent influx of calcium (Matthews et al., 1989a). Hence, in the present study, 
the much reduced anti-IgE-stimulated histamine secretion in chloride free buffers 
may be due to a lack ofhyperpolarization driven calcium influx which was essential 
to support the mast cell degranulation. Similar findings were reported by Friis et al. 
(1994) and Redmp et al. (1997) which supported the hypothesis that the inward 
movement of chloride through chloride channels may be part of the mechanism 
controlling histamine secretion since the removal of extracellular chloride in these 
studies by either isethionate or gluconate anions inhibited antigen-stimulated 
histamine secretion. 
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In the current study, we further evaluated the hypothesis by studying the effects of 
chloride depletion on the increase in free intracellular calcium concentration induced 
by anti-IgE. The removal of extracellular chloride significantly reduced both anti-
IgE induced histamine release and the influx of extracellular calcium. In general, 
complete removal of chloride with gluconate seems to be more effective in reducing 
the histamine release and the increase in intracellular calcium induced by anti-IgE. 
This observation suggests that even minute quantity of C1' remaining in the buffer 
may still be sufficient to partially fulfil the normal physiological requirement for C1'. 
The importance of replacing all C1' ions is highlighted when our results were 
compared with those reported by Friis et al (1994). These authors replaced only 
NaCl with the corresponding isethionate and gluconate salt and, in contrary to our 
observations, found that partial replacement of chloride by gluconate produced a 
weaker reduction of anti-IgE induced histamine release than partial replacement by 
isethionate. Hence, the reduced calcium influx on anti-IgE-stimulated mast cells by 
removal of extracellular chloride apparently accounts for the reduced histamine 
release from rat peritoneal mast cells activated in the absence of extracellular 
chloride. 
In previous studies (Matthews et al., 1989a; Romanin et al., 1991; Hoth et al., 1993), 
the main effects of C1' influx during immunologic mast cell activation has been 
suggested to be the facilitation of Ca�+ influx through calcium channels in the plasma 
membrane and hence maintaining the sustained elevation of intracellular calcium for 
maximum release. The current study supported this hypothesis by observing the 
suppression of the sustained elevation of calcium in the C1" depleted buffers. 
However, we have also observed a reduction in the initial transient increase of 
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intracellular calcium. Since it has been suggested that this initial transient increase is 
due to the release of calcium from intracellular stores (White et al., 1984), the rate 
and magnitude of this transient peak in theory would not be affected by chloride 
depletion if C1' influx affected only the later sustained elevation. The current 
observation hence suggests that depletion of extracellular chloride may also affect 
the release of calcium from the intracellular stores. Previous studies (Friis et al., 
1994; Redrup et aL, 1997) have demonstrated that although influx of C1' was 
immediately initiated upon immunologic mast,cell activation in H E P E S buffer, the 
rate of onset was significantly delayed with a reduced influx of C1' in C1" depleted 
buffers. Synchronisation may exist between the induction of hyperpolarization 
mediated by the influx of extracellular C1' and release of calcium from intracellular 
stores, hence a delay in the onset of C1' influx will then upset this requirement. 
Furthermore, the reduction of chloride influx during the initial activation of mast 
cells in C1' free buffer may render the cytoplasm to be less negatively charged than in 
H E P E S buffer and hence making the release of cationic Ca�+ from the intracellular 
stores less facilitated. 
Activation of mast cells by either anti-IgE or compound 48/80 was immediately 
followed by an initial increase in free intracellular calcium (Kuno et aL, 1990) which 
is believed to be due to the release of calcium from intracellular sources by IP3. 
Although both compound 48/80 and anti-IgE induced mast cell activation involve a 
G-protein coupled with the activation ofPLC, the identity ofthis protein is believed 
to be different for the two secretagogues. Compound 48/80 appeared to activate a 
Gi-protein subtype, since pretreatment of rat peritoneal mast cells with the islet-
activating protein, pertussis toxin, resulted in a marked reduction ofhistamine release 
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in compound 48/80 activated cells (Nakamura & Uni, 1984). Moreover, the 
suppression effects of pretreatment with pertussis toxin (PT) on compound 48/80 
induced activation of the Ca^^-permeable channel using the patch clamp technique 
suggested that the Ca^^-permeable channel was also activated via actions of a PT-
sensitive GTP-binding protein (Kuno et al., 1990). In contrast, immunologic 
activation of mast cells is PT insensitive and is enhanced by cholera toxin. Hence 
the G protein involved in the immunologic activation of mast cells is believed to be a 
Gs-protein subtype. In addition to the PLC activating G protein, it had been showed 
that compound 48/80 can directly activate another G protein (Ge) which is coupled 
directly to exocytosis. Through the activation of this GE protein, compound 48/80 
was capable of inducing secretion in a mechanism that bypassed P L C (Aridor et al., 
1990). 
In terms of histamine release, the differences between mast cell activation by anti-
IgE and compound 48/80 become apparent when the activation is induced in the 
absence of extracellular calcium (Tasaka et aL, 1986; Kuno et al., 1990). In the case 
of anti-IgE, the transient increase in calcium is insufficient to initiate complete 
exocytosis but is essential for the physiological opening of the plasma membrane 
calcium channels (Felder et al., 1994; Putney, 1986). The subsequent influx of 
extracellular calcium then facilitates the maximum release of mediators. The 
requirement for the influx of extracellular calcium is therefore obligatory for anti-IgE 
induced exocytosis. In contrast, compound 48/80 can invoke a more rapid, more 
prominent and higher level of intracellular calcium release to produce a significant 
sub-maximal level of histamine release even in the absence of extracellular calcium 
(Kuno et al., 1990; Pintado et aL, 1984). Hence, the requirement for the influx of 
90 
extracellular calcium is not obligatory for compound 48/80 induced exocytosis. 
Since the removal of chloride ions was thought to affect mainly the influx of 
extracellular calcium, it is not surprising to observe that C1' depletion did not 
significantly affect histamine release induced by compound 48/80. This observation 
also agrees with a previous patch clamp study which demonstrated that the activation 
of the chloride current was not essential for the stimulation of exocytosis by 
compound 48/80 but may enhance secretion at suboptimal stimulation (Dietrich & 
Lindau, 1994). 
Unlike the case with anti-IgE activation, compound 48/80 induced increase of 
intracellular calcium produced a more distinct transient peak with a much reduced 
sustained elevation. Although the magnitude of this transient peak was not 
significantly different in cells activated in H E P E S buffer or the two chloride free 
buffers as illustrated by the comparison of the A U C values, it is obvious from fig. 
3.13 and fig. 3.14 that initiation of this calcium peak was significantly delayed in the 
C r free buffers. The delay in initiation may once again be due to the reduced influx 
of chloride at the time of cell activation which renders the electrochemical 
environment of the cytoplasm to be less favourable for the release of intracellular 
calcium. Failure ofchloride depletion to significantly reduce the final increase ofthe 
calcium transient peak associated with compound 48/80 may be due to a more 
persistent or higher concentration 0fIP3 production by compound 48/80. 
Since calcium ionophore A23187 circumvents all membrane associated calcium 
channels to transport calcium ions directly from the extracellular medium to the 
cytosol (Foreman et al., 1973), it was expected that chloride depletion would not 
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have any significant effect on the histamine release induced by both ionophore 
A23187 and ionomycin. However, histamine release induced by both ionophores 
were inhibited by replacing all the C1' ions with gluconate. This may due to certain 
direct effects of chloride ions on calcium transport by ionophores. Another 
explanation would be that gluconate may be a better chelator of calcium than 
chloride and hence compete with ionophore for free calcium. 
In principle, both calcium ionophore A23187 and ionomycin are capable of 
transporting calcium through the same mechanism and hence a similar pattern in 
their induced histamine release in chloride free situation would be expected. 
However, significant inhibition ofhistamine release in both chloride free buffers was 
observed in rat peritoneal mast cells activated by ionomycin while significant 
inhibition of ionophore A23187 induced histamine release was only observed in 
gluconate buffer. The [Ca^ ]^i increase in ionomycin activated mast cells was also 
suppressed during the removal of extracellular chloride. Since ionophore A23187 
interferes with the calcium signal using fura-2 measurement (Pfeiffer et al., 1974), 
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the [Ca ]i increase in ionophore A23187 activated mast cells was not done in this 
experiment. By comparing the results of histamine release and intracellular calcium 
induced by ionomycin, the inhibition ofhistamine release correlated with the calcium 
influx inhibition. Although previous studies and the current study have reported that 
ionophore A23187 is more potent than ionomycin in inducing responses such as 
increasing the H2O filtration rate across an endothelial cell monolayer (Suttorp et al., 
1989); increasing ^'Ca release from pre-loaded cultures of fetal rat long bones 
(Lorenzo & Raisz, 1981) and stimulating histamine secretion from rat and hamster 
peritoneal mast cells (Leung & Pearce, 1984), it is not yet clear why ionomycin 
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induced consistently smaller increases in histamine release than equivalent 
concentrations of A23.187. In fact, this difference was somewhat surprising, since 
ionomycin forms 1:1 complexes with divalent cations while 2 ionophore : 1 divalent 
cation complexes are formed by A23187. Hence, theoretically ionomycin should be 
a more efficient Ca�+ transporter. Similar results was also observed by Lages & 
Weiss (1995) who reported that A23187 induced a greater extent of dense granule 
secretion in human platelets than equimolar concentration of ionomycin. In their 
study where Ca^^ levels were monitored for both ionophores it was found that the 
extents of the platelet responses to A23187 and ionomycin could be directly related 
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to the magnitudes of the [Ca ]i increase. They concluded that the decreased extent 
of the response seen with ionomycin was primarily due to the lower [Ca^^]i increase 
produced. The differences in ionophore potency were suggested to be due to certain 
ionophore-specific factors and differences in intracellular environment which 
directly affect the ability of the ionophores to initiate Ca�+ transport and/or 
intracellular release. In addition, DiVirgilio and Gomperts (1983) reported that 
A23187, but not ionomycin, stimulated secretion of lysosomal enzymes from 
cytochalasin B-treated rabbit neutrophils in the absence of extracellular Ca】+ and this 
difference in response was probably due to the depletion of cytosolic Mg2+ by 
A23187 which did not occur with ionomycin. 
By specifically inhibiting the calcium transporting ATPase, thapsigargin depletes 
calcium from the intracellular storage sites and leads to the opening of calcium 
channels in the cell membrane (Alfonso et a/., 1994; Thatsrup et al., 1989). The 
pretreatment of cells with thapsigargin leads to the opening of IcRAc channel and the 
subsequent addition of calcium flows through these opened channel to increase 
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intracellular calcium. It has been suggested that antigen and thapsigargin promote 
influx of Ca2+ in RBL-2H3 cells by similar mechanisms (Ali et al., 1994). The 
increase in the intracellular calcium observed in thapsigargin activated mast cells is 
believed to be equivalent to the sustained elevation of intracellular calcium observed 
in anti-IgE activated cells. Hence similar to the observation in anti-IgE activation, 
the replacement of chloride ions by either isethionate or gluconate in the present 
study again suppressed mast cells calcium influx activated by thapsigargin. 
In the current study, the results of calcium influx experiments with thapsigargin fitted 
with the hypothesis that the chloride ion was important for the influx ofcalcium from 
extracellular medium through opened calcium channel. However, the result of 
isethionate replacement of chloride ions on histamine release did not correlate with 
the calcium influx result. Although thapsigargin produced the highest increase in 
intracellular calcium (Table 3.2), the corresponding histamine release was not the 
highest among the four secretagogues. This hence suggested that in addition to 
calcium, other factors may regulate histamine release induced by the other 
secretagogues in particular compound 48/80 and ionophore A23187. Furthermore, 
the relatively lower release of histamine induced by thapsigargin in H E P E S buffer 
may paradoxically due to the excessive influx of extracellular calcium which hinders 
the degranulation process. Pretreatment of mast cells in calcium free buffer with 
thapsigargin may mimic the condition of activating the mast cells with high 
concentration of calcium after prolonged incubation in Ca�+ free media as reported 
by Douglas & Kagayama (1977). They had demonstrated that following incubation 
in calcium free medium for 2 hrs, mast cells degranulated when subsequently 
exposed to media rich in calcium. The degranulation resembled that seen with 
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specific antigen or compound 48/80. However, they had also noticed that excess 
calcium (110 m M ) hindered expulsion of granule from mast cells which might be 
due to the suppression of migration or expulsion of granule from the exocytosis pits 
within the cellular domain. 
The observation that thapsigargin released more histamine in isethionate buffer than 
in H E P E S buffer may be similarly explained by the inhibitory action of excessive 
intracellular calcium. With reference to Table 3.2, fig. 3.18 and fig. 3.22, although 
the amount ofcalcium influx induced by thapsigargin (0.01 ^ M ) in isethionate buffer 
was half of that induced in H E P E S buffer, it is comparable with that induced by 
ionomycin (0.5 ^iM) in H E P E S buffer. The level of histamine release induced by 
0.01 p M thapsigargin in isethionate buffer and 0.5 p M ionomycin in H E P E S buffer 
were also comparable. This level of calcium influx may facilitate mast cell 
exocytosis with less or even without the inhibitory action associated with the massive 
calcium increase observed with thapsigargin in H E P E S buffer and hence no 
significant reduction in histamine release in the isethionate buffer. 
The depletion of chloride ions from the buffer did not induce any membrane 
destabilising effect on the mast cells as triton-X 100 induced histamine release was 
not affected. Unlike the non-cytotoxic mast cell secretagogue calcium ionophore 
A23187, triton-X 100 was a cytotoxic compound which disrupted the plasma 
membrane and resulted in irreversible damage to the cell, and finally the contents of 
the mast cell granules were expelled. Hence, the histamine release induced by triton_ 
X 100 in Cr free buffers was similar to that induced in H E P E S buffer, since this 
activation pathway is not dependent on extracellular ions. 
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3.5. Conclusion 
In accordance with previous observations that C1' influx was also reduced in C1' 
depleted buffer (Friis et al., 1994; Redrup et aL, 1997)，our results further supports 
the hypothesis that C1' influx modulates immunological activation ofmast cells via a 
calcium dependent process. In the present study, antigen-stimulated histamine 
secretion from rat peritoneal mast cells and the related intracellular calcium increase 
were reduced or inhibited when extracellular chloride was replaced by either 
isethionate or gluconate anions. For the compound 48/80 induced mast cell 
activation, our observations also agree with previous patch clamp studies which 
showed that the activation of the chloride current was not essential for compound 
48/80 stimulated exocytosis (Dietrich & Lindau, 1994). Hence, the involvement of 
G proteins which coupled directly to exocytosis in this activation may account for the 
observation that removal of the extracellular chloride had no effect on compound 
48/80 activated rat peritoneal mast cells either for histamine secretion or the 
intracellular calcium increase. 
O n the other hand, C1" ion depletion experiment on the ionophores and thapsigargin 
produced results which were more complicated than simple correlation of C1' 
depletion to calcium influx suppression. Differences between ionophore A23187 and 
ionomycin may be due to difference in their physical and functional properties 
related to cation transports. Failure of isethionate replacement of C1' to inhibit 
thapsigargin induced histamine release may be due to the insufficient reduction in the 
influx of calcium or due to other non-calcium related properties of thapsigargin. 
Obviously, further experiments are required to clarify the relations between C1' ion 
and mast cell activation by these two types ofsecretagogues. 
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Chapter 4 
DSCG AND CHLORIDE CHANNEL BLOCKERS 
(NPPB, DIDS, SITS, DPC, IAA-94 & FLUFENAMIC ACID) 
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4.1. Introduction 
4.1.1. Roles of chloride channels 
Chloride is the most abundant physiological anion. Several pathways for chloride 
exchange exist, including Cl'-HCO3" exchange, Na+/KV2Cl_ cotransport, K+-C1_ 
cotransport and chloride channels (Pusch & Jentsdh, 1994). Chloride channels are 
membrane proteins that mediate passive transport of chloride ions across the lipid 
bilayer by forming an aqueous difftision pore. They are present in the plasma 
membrane of probably all eukaryotic cells (Jentsch, 1996). 
Plasma membrane chloride channels have been shown to participate in regulatory 
volume decrease (RVD) as well as in the regulation of intracellular pH. In many 
epithelia, chloride channels are essential for the transport of salt across the cell layer 
(Jentsch, 1993). For excitable cells that change their membrane potential over wide 
ranges, activation of chloride channels stabilises the membrane potential. This has 
an inhibitory effect on action potential generation because chloride equilibrium 
potential is close to resting membrane potential (Valverde et aL, 1995). For 
example, physiological functions of y-aminobutyric acid ( G A B A ) and glycine 
receptors in neurons and chloride channels in skeletal muscle are based on this effect. 
In mast cells and other nonexcitable secreting cells, opening of chloride channels 
d a m p s the membrane voltage at negative values and thereby increases the driving 
force for entry of external calcium ions, which in turn stimulates secretion (Pusch & 
Jentsch, 1994). 
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4,LLL Chloride channel classification 
Classically, chloride channels are divided into two groups: ligand-gated and voltage-
activated. Alternatively, they are separated into broad groups according to their 
conductance: (1) channels of large conductance (200-400pS), (2) channels of 
intermediate conductance (20-80pS) and (3) channels of small conductance from 
sub-pS to lOpS. A s it can be seen in lymphocytes, three distinct C1' channels have 
been identified: a large-conductance (300-400pS) channel; a medium-conductance 
(-40pS) channel; and a small-conductance (l-2pS) channel (Phipps et al., 1996). 
〇n the other hand, chloride channels can be categorised according to their various 
types ofregulation. The binding of an external messenger molecule activates ligand_ 
gated chloride channels. Typical examples of this class are postsynaptic G A B A and 
glycine activated chloride channels (Franciolini & Petris, 1990). There are at least 
two receptor types for the neurotransmitter G A B A , designated G A B A A and G A B A g 
receptors. Activation of G A B A e receptors opens K channels through a G-protein 
system, whereas activation of G A B A A receptors leads to the direct opening of C1' 
channels via allosteric modification of the receptor-channel protein. The reversal 
potential for potassium is generally —90 to -lOOmV, while that of chloride varies 
significantly from cell to cell but often is -65 to 7 0 m V (Franciolini & Petris, 1992; 
Olsen & Tobin, 1990; Slaughter & Pan, 1992; Tillakaratne etal., 1995). 
Adenosine 3',5'-cyclic monophosphate (cAMP)-dependent chloride channels are 
activated by a rise in intracellular c A M P . A n important example is the cystic fibrosis 
transmembrane conductance regulator (CFTR) chloride channel which is the gene 
product defective in cystic fibrosis (Anderson et aI., 1992; Halley et al,, 1990; 
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Jentsch, 1996). It is largely voltage independent with a single-channel conductance 
of 5-lOpS and a selectivity sequence of C1. > Br _ > F. Another example is P_ 
glycoprotein which is encoded by the human M D R 1 gene. C F T R is believed to be a 
channel itself, and phosphorylation of the linker region (a short, charged region 
between two ATP-binding domains) regulates channel opening and closing in many 
cells. In contrast, P-glycoprotein appears to be a channel regulator, and 
phosphorylation of the linker region influences the activity of a distinct channel 
protein (Higgins, 1995). The physiological functions for P-glycoprotein includes cell 
detoxification, the removal of nonlipid compounds from membranes, hormone 
secretion and control ofphospholipid distribution. A recent and unexpected finding 
is that expression of P-glycoprotein following transfection into NIH3T3 fibroblasts 
can also influence cell volume-activated chloride currents (Higgins, 1995). 
Volume-dependent chloride channels showing outward rectification are activated by 
an increase in cell volume. The functions of these channels include the maintenance 
of a constant cell volume, p H regulation, and control of membrane potential. A 
heterogeneous family of multiple volume-activated C1' channels exist, including 
CLC-2 (a member ofthe C L C gene family), P-glycoprotein, Icin and phospholemman 
(Nilius et al., 1996; Sakai et al., 1996). It was shown that Icin, a chloride channel 
cloned from epithelial cells, was blocked by N P P B (IC50 = 8x10'^ mol/l), as well as 
phenol derivatives or benzo-y-pyrone-2-carboxylate derivatives (Wangemann et al., 
1986). 
Another important class of chloride channels is calcium-dependent chloride 
channels, which are activated by elevated intracellular calcium. It might be 
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functionally important for the control of the membrane potential and the drivina 
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force for Ca�+ influx during agonist stimulation. Besides, there is evidence that 
DIDS and N P P B (Nilius et al., 1997) can block these channels. At present, little 
information is available for this type of channels, and no such channel has yet been 
cloned. 
4.1.1.2. Chloride channel blockers 
Mammalian cell membranes harbour several types of chloride channels, chloride-
cation symporters/cotransporters, and several classes of anion exchangers/antiporters. 
Chemical probing has played a central role in the structural and functional 
delineation of the various anion transport systems. In general, a chemical probe is 
best defined as a natural or synthetic molecule that is designed to explore an 
otherwise inaccessible area. 
The common feature that seems to confer to anionic probes their high affinity and 
differential selectivity for putative targets is the presence of an additional 
hydrophobic moiety that has variable e' acceptor/donor capacity and is spatially 
positioned relative to the charge bearing core. Moreover, the anion probe is 
comprised primarily of ring structures since they otTer numerous possibilities for 
group substitutions and inclusion ofreporter groups. (Cabantchik & Greger. 1992) 
Iii this study, six chlonde channel blockers are chosen for comparing with D S C G for 
thdr effects in mast cell activation in order to evaluate the role ofchlonde channels 
in mast cell activation and if D S C G mediates its action through chloride channel 
blocking. They include 4.4'-diisothiocyanostiIbene-2.2"-disulfonic acid (DIDS), 4-
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acetamido-4 ‘ -isothiocyanatostilbene-2,2 ‘ -disulfonic acid (SITS), 5-nitro-2-(3-
phenylpropylamino)-benzoic acid (N??B), n-phenylanthranilic acid (DPC), 
flufenamic acid and indanyloxyacetic acid 94 (IAA-94) (chemical structures shown 
in Fig. 4.2&Fig. 4.3). 
D I D S and SITS are related to disulfonic stilbene (DS). D S and its derivatives are 
among the most potent of red cell chloride exchange inhibitors and their inhibitory 
potencies span a concentration range of over four orders of magnitude. The 
inhibitory potencies are largely dependent on the chemical nature of the substituent 
group (see fig. 4.2). The electron acceptor capacity and the hydrophobicity of the 
4,4'-substituent groups are particularly important for the inhibitory potency. The 
second factor which is important is the molecular size and planarity of the stilbene 
structure. The ethylene bridge contributes to the planarity of the conjugated ring 
structures and to the e' withdrawing capacity of the 4,4'-groups, both of which are 
reflected in the relative position and mobility of the rings and reactivity of attached 
groups. Trans-stilbenes that carry no anionic groups hardly affect Cl'-X in which 
substituent X is N C S and NHCOCH3 as in DIDS and SITS respectively. Also, the 
presence of sulfonic groups or carboxylic groups determines to a large extent the 
potency o f D S as reversible blockers ofCl'-X. (Cabantchik & Greger, 1992) 
DIDS and D P C inhibited the Ca"^-activated C1" current (IC50 values between 16.5 
and 306^iM) in rat vascular smooth muscle cells in short-term primary culture with 
no effects on the inward Ca�+ current and on internal Ca�+ loading. These 
experiments indicated that the inhibition of C1' current by these compounds was due 
to a direct interaction with the C1" channel (Baron et al., 1991). Also, the 
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endogenous Ca^^-activated C1' currents of control oocytes were abolished by DIDS 
(50^iM) (Cumingham et al., 1992). In contrast, the cAMP-stimulated currents of 
CFTR-expressing oocytes were DIDS insensitive and were inhibited only 5 0 % when 
bath C r was replaced by gluconate or glutamate. In addition, N P P B (50^M) and 
D P C (3mM) reduced the cAMP-evoked currents by only 10%. (Cunningham et al., 
1992). 
The effect of D S agents on chloride channels in mast cells is different from that in 
other systems. DIDS irreversibly blocked the chloride channel after incorporation 
into lipid bilayers in Torpedo electroplax (Cabantchik & Greger, 1992) while the 
effect in mast cells was partly reversible (Matthews et al,, 1989a). The action of 
DIDS in mast cells was complex and a simple explanation for the effect ofDIDS on 
the delayed C1" current (1.6pS) is that DIDS enters the channel from either side ofthe 
cell membrane and blocks it (open-channel blocker of the delayed current). This is 
contrary to general belief that the D S inhibitory sites are demonstrably exofaciaL 
The delayed C1' current was believed to provide the negative membrane potential 
necessary for the plateau phase of elevated [Ca^ ]^i in secretion. Although this current 
can be stimulated by a number of external agonists, it is suggested that it is activated 
indirectly via second messengers rather than directly by the agonists because the 
activation is slow in onset and outlasts the presence ofthe agonist. Also, application 
ofDIDS for more than a few seconds led to an irreversible blockade, suggesting that 
there is both a rapid but reversible, and a slower but irreversible block ofthe channel. 
In another study, the inhibition of the C1' current in rat peritoneal mast cells by 
extracellular DIDS (3 & 30^iM) is voltage and time dependent during the induction 
by intracellular application of c A M P and secretion from intact cells stimulated with 
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compound 48/80 (Dietrich & Lindau，1994). Furthermore, DIDS (0.3 to 30^M), 
produced a concentration-related inhibition of antigen-stimulated histamine secretion 
in rat mast cells but DIDS did not inhibit the antigen-stimulated increase of chloride 
uptake at concentrations up to 3 0 ^ M (Friis et al., 1994). 
Turning to DPC, flufenamic acid and N P P B , they are arylaminoalkyl benzoates. 
Physiologically, NPPB, D P C and flufenamate have been found to effectively block 
C r exchangers, various C1" channels, and nonselective cation channels. N P P B is the 
most potent member of the group and the reactivity relating to the chemical structure 
(refer to fig.4.3) of the group is characterized as follows: 1) the potent compounds 
are lipophilic due to the apolar residue (e.g. phenyl- or cycloalkyl group); 2) most of 
the inhibitors are secondary amines; 3) the carboxylate group of the benzoate moiety 
must be in the ortho position to the amino group; 4) introduction of substituents into 
the benzoate moiety e.g. - N O 2 (in meta position to the carboxylate group), or by -C1 
(in para position to the carboxylate group) results in an increase of inhibitory 
potency; 5) a spacer between the amino bridge and the phenyl ring increases the 
affinity for the C1' channel by several orders of magnitude. (Wangemann et al., 
1986). 
A number of phenylanthranilic acids, including DPC, are inhibitors of chloride 
specific channels in several secretory and absorptive epithelial cell systems including 
the porcine thick ascending loop of Henle, bovine and canine tracheal epithelial cells, 
bullfrog corneum, guinea pig isolated gastric mucosa, shark rectal gland and rat 
parotid aciner cells (Heisler, 1991). D P C and flufenamic acid are also closely related 
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to a large group of nonsteroidal anti-inflammatory substances and are found to block 
the Cr exchanger, usually Cr-HCO3" exchangers. 
D P C and N P P B have been reported to block C1' channels in epithelial cells in the 
thick ascending limb of Henle (Wangemann et aL, 1986). Moreover, N P P B has been 
demonstrated to act on the outer membrane aspect of the channel. Although N P P B is 
reported as a C1" channel blocker while furosemide is a cotransporter blocker (Na+-
K+-2Crsymport) (Meyer et al., 1996), the structural similarity of N P P B and loop 
diuretics of the furosemide type has prompted the structural modification of loop 
diuretic molecule with the hypothesis that Cl' cotransporters blockers could possibly 
be converted into Cl' channel blockers and vice versa. 
In mast cell studies, N P P B dose-dependently (5 to 20^M) inhibits anti-IgE-
stimulated chloride uptake into mast cells and the corresponding histamine secretion 
implying that chloride channel activity is related to the mechanism of histamine 
secretion (Redrup et al., 1997). In addition a comparable concentration o f N P P B has 
been reported to block the delayed C1" current in peritoneal mast cells (Matthews et 
aL, 1989a). Remarkably, N P P B (IC50 23^iM) and D P C (IC50 190^iM) inhibited not 
only the chloride current but also the calcium current in rat mucosal-type mast cells. 
In contrast, DIDS (500^iM) blocked only the chloride current (Reinsprecht et al., 
1995). 
Independent of their activity against the cyclo-oxygenase, flufenamic acid and other 
non-steroidal anti-inflammatory drugs fNfSAIDs) with a fenamate structure had been 
shown to inhibit polymorphonuclear leukocyte (PMN) functions such as L T B 4 
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release (IC50 21-25^iM) or calcium ionophore A23187-triggered degranulation (IC50 
21-32^iM) (Kankaanranta et al., 1994). Moreover, flufenamic acid inhibits Ca:+ 
influx in human P M N (Kankaanranta & Moilanen, 1995). Besides, it was found that 
flufenamic acid (10-100p,M) suppresses proliferation of human peripheral blood 
lymophocytes by a mechanism which involves inhibition of Ca�+ influx and is not 
related to inhibition of prostanoid synthesis (Kankaanranta et al., 1996). 
Indanyloxyacetic acid 94 (IAA-94) is reported as a high-affinity ligand for the 
chloride channels from kidney and trachea (Landry et al,, 1990). The chloride 
channel blocker IAA-94 produced a concentration-dependent reversible flickering 
block of the endosomal channel from rabbit kidney cortex with a Ki of 1 5 ^ M 
(Reeves & Guricli, 1994). Moreover, IAA-94 (lOO^M) and N P P B (10-40^iM) were 
identified as full blockers of cardiac swelling-induced chloride current (Sorota,1994). 
4.1.2. A ims of study 
In the present study, w e attempted to further investigate the effects of chloride influx 
on mast cell activation and to evaluate the hypothesis that D S C G inhibits mast cell 
activation through the blocking of chloride channels by comparing the effects of 
D S C G and chloride channel blockers on rat peritoneal mast cells activated by 
different secretagogues. These secretagogues with different calcium mobilization 
profile should provide useful information about where these blockers interfere in the 
mast cell activation pathway. Moreover, calcium influx was measured by ^ ^ a 
uptake in order to correlate with observation obtained in histamine release 
experiments. W e attempted to measure the free intracellular calcium concentration 
using the fluorescent dye fura-2, but we found that the chloride channel blockers 
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interfered with the fluorescence produced by the dye. The chloride channel blockers 
caused a substantial quenching on the fura-2 signal, so we could not use this method 
to measure calcium influx. Due to the large number of cells required for the 
measurement of^^Ca^^ influx, only the top concentration of each blocker was tested. 
4.2. Materials and methods 
The materials and methods used were described in chapter 2. The dmgs NPPB, 
flufenamic acid and IAA-94 were dissolved in D M S O while D P C was dissolved in 
ethanol at suitable stock concentrations and were stored in the freezer at -20°C. For 
D S C G , DIDS and SITS, they were dissolved in buffer at suitable stock 
concentrations when used. Controls were performed to test the effects of a final 
concentration of 0.1% D M S O or ethanol on the secretagogue induced histamine 
release. It was found that D M S O or ethanol at this concentration did not alter the 
secretagogue induced histamine release. Moreover, corresponding controls were 
performed to incubate the test compounds for 0 and 10 minutes. It was observed that 
there was no change in the spontaneous histamine release. In the study, 0 and 10 
minutes were chosen as the preincubation times as significant tachyphylaxis after 10 
minutes preincubation with D S C G is well known. Results are expressed as mean 土 
S E M and are corrected for the spontaneous histamine release or ^ ^a^^ uptake as 
appropriate. 
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4.3. Results 
4,3.1. Effects of DSCG and the test blockers on immunologically induced 
histamine release from rat peritoneal mast cells 
Generally, rat peritoneal mast cells spontaneously released < 15% of total cellular 
histamine in buffer after purification. Neither D S C G nor the six chloride blockers 
alone altered this spontaneous histamine release. To study the effects of these 
compounds on mast cell activation, purified rat peritoneal mast cells were challenged 
with secretagogues to induce a further 20-40% of the total cellular histamine release. 
Cells which were activated without preincubation with D S C G showed a dose 
dependent inhibition of anti-IgE induced histamine release. Significant inhibition 
was initially observed at 10'^  M and increased to the maximum level of 43.3±6.6 % 
inhibition at 10'^  M . In contrast, a 10 minutes preincubation with the drug prior to 
stimulation of anti-IgE abolished the inhibitory potency of D S C G over the 
concentration range used (Fig. 4.4). 
Dose dependent inhibition of anti-IgE induced histamine release was observed in 
cells which were activated with or without preincubation with DIDS, SITS, NPPB, 
D P C or flufenamic acid. For DIDS, the dose inhibition curve after 10 minutes 
preincubation was almost identical to that after 0 minutes preincubation. Significant 
inhibition was observed initially at 10_) M and increasing to the maximum inhibition 
of 111.1±4.6 % and 104.6±7.6 % respectively at 10'^  M in 0 and 10 minutes 
preincubation (Fig. 4.5 & Table 4.1). Similarly, the effects o f D P C were not affected 
by preincubation (Fig. 4.8) although the maximum inhibition was much lower than 
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D I D S at 44.1±9.3 % and 37.4±5.2 % respectively for 0 and 10 minutes 
preincubation. 
For N P P B and flufenamic acid after 0 or 10 minutes preincubation, substantial and 
similar levels of inhibition of histamine release was observed only at concentrations 
higher than 10.) M for the two preincubation times (Fig. 4.7 & Fig. 4.9). 
107.8土4.7 % and 91.0±5.2 % inhibition was observed at 5xl0"' M N P P B and 
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2.5x10" M flufenamic acid respectively after 0 minutes preincubation (Table 4.1). 
At lower concentrations, histamine release from cells preincubated with N P P B and 
fIufenamic acid for 10 minutes were more inhibited than that from cells without prior 
incubation with these blockers. SITS was significantly more potent in inhibiting 
anti-IgE induced histamine release after 10 minutes preincubation (Fig. 4.6). 
M a x i m u m inhibition were 75.2±4.3 % and 104.6土7.0 % respectively for 0 and 10 
minutes preincubation (Table 4.1). For IAA-94, no significant dose-related 
inhibition was observed when the cells were activated without prior incubation with 
the drug (Fig. 4.10). Significant inhibition of 42.3土6.1 % was only observed at 
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2.5xl0' M after 10 minutes preincubation. 
By comparing the IC50 values of the blockers on the rat peritoneal mast cell 
activation by anti-IgE (Table 4.2), N P P B was the most potent having the IC50 value 
of 1x10、、M and 3xlO'' M for 0 and 10 minutes preincubation respectively. In 
contrast, D P C and IAA-94 was the least potent which had < 5 0 % of the maximum 
inhibition on mast cell activation. The IC50 value is defined as the concentration ofa 
compound which inhibits 50 % ofthe secretagogue induced histamine release and is 
extrapolated from the corresponding dose-inhibition curves. From table 4.2, the 
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order of potency was N P P B > DIDS > Flufenamic acid > SITS > D P C » IAA-94 
for 0 or 10 minutes preincubations. 
4.3.2. Effects of DSCG and the test blockers on compound 48/80 induced 
histamine release from rat peritoneal mast cells 
In general, all the tested compounds were capable of inhibiting histamine release 
induced by compound 48/80, however an interesting observation was found in the 
inhibiting effect of D S C G , NPPB, DIDS and SITS on rat peritoneal mast cell 
activation by compound 48/80 when different 0 minutes preincubation protocols 
were evaluated. In protocol 1, purified mast cells were added to test tubes containing 
both compound 48/80 and the test compound. In contrast, in protocol 2, both 
purified mast cells and compound 48/80 were added simultaneously to test tubes 
containing only the test compound. The corresponding anti-IgE experiments are also 
included for comparison. Significant difference in the inhibitory potency of 10'^  M 
D S C G , 6xlO"'MNPPB, 3xlO'^ M DIDS, 3xl0"' M DIDS, 6x10'' M SITS and 3x10.4 
M SITS was observed between the two protocols with protocol 2 being less 
inhibitory (Table 4.3). However, this situation was not observed in anti-IgE 
experiments under the same conditions or in inhibition induced by theophylline. It 
was hence concluded that these anionic blockers might chemically interact with 
compound 48/80 when they were mixed in solution with the polycationic 
secretagogue prior to exposure to mast cells. In consequence, the effective 
concentration of free compound 48/80 available for mast cell activation was reduced 
and hence reduction of histamine release. In order to avoid such non-
pharmacological interaction, protocol 2 was adopted for all experiments involving no 
preincubation with the test compounds. 
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D S C G inhibited histamine release from rat peritoneal mast cells which were 
activated by compound 48/80. Significant inhibition was again initially observed at 
10_5 M and increased to the maximum level of 39.6±4.4 % inhibition at 10'^  M . 
However, it was found that the maximum inhibition level for compound 48/80 was 
slightly lower than that of anti-IgE. Although the inhibitory response was 
significantly reduced after 10 minutes preincubation (Fig. 4.11), it was not 
completely abolished as in the case of anti-IgE activation. The inhibition produced 
by the chloride channel blockers in mast cells activated by compound 48/80 was 
similar to that observed with anti-IgE induced histamine release. Cells which were 
preincubated with DIDS for 0 or 10 minutes showed identical dose inhibition curves 
against compound 48/80 induced histamine release. Significant inhibition was 
observed at 10'^  M and 100 % of inhibition was achieved at 6x10'^ M (Fig. 4.12). 
The potency of SITS was lower than DIDS in inhibiting compound 48/80 induced 
histamine release. Significant inhibition was observed only at concentrations higher 
than 10_4 M and the maximum inhibition reaching nearly 100% was only observed at 
6x10-3 M with 10 minutes preincubation (Fig. 4.13). For NPPB, significant 
inhibition was observed only at the highest concentration of 5x10.5 M tested with 
maximum inhibition of 49.2±6.3 % following no preincubation (Fig. 4.14 & Table 
4.1). For flufenamic acid, the inhibitory response was significantly enhanced after 
preincubation with cells for 10 minutes to 68.3±5.6 % from 26.0+3.2 % inhibition at 
the highest concentration of 2.5x10'^ M (Fig. 4.16). Under the same conditions, cells 
preincubated with D P C (10'^  - 2x10"^ M ) and IAA-94 (5xlO"^ - 2.5x10"^ M ) had no 
significant effect on histamine release induced by compound 48/80 following 0 or 10 
minutes preincubation periods (Fig. 4.15 & Fig. 4.17). 
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By comparing the IC50 .values of these blockers, the situation was different from that 
of anti-IgE experiments. Now, DIDS became the most potent blocker which had the 
IC50 of 1.5xlQ-) M in either 0 or 10 minutes preincubation time (Table 4.2). Similar 
to the result in anti-IgE, D P C and IAA-94 were once again the least potent. 
M a x i m u m inhibition ofDPC was only 2.4+9.3 % and 6.2土6.7 % in 0 and 10 minutes 
preincubation time respectively while the maximum inhibition of IAA-94 was 
24.6±5.7 % and 11.7土6.2 % in 0 and 10 minutes preincubation time respectively 
(Table 4.1). From table 4.2, order of potency was DIDS > N P P B > SITS » 
Flufenamic acid > D P C = IAA-94. 
4.3.3. Effects of DSCG and the test blockers on ionophore A23187 induced 
histamine release from rat peritoneal mast cells 
It is obvious from fig. 4.18 that D S C G , with or without 10 minutes preincubation 
with cells, had no effect on the histamine release induced by ionophore A23187. In 
contrast, all the test blockers except IAA-94 showed a dose dependent inhibition of 
ionophore A23187 induced histamine release for 0 and 10 minutes preincubation 
times. In general, there are no significant difference between cells for 0 and 10 
minutes preincubation. As observed in anti-IgE induced histamine release, DIDS 
produced the maximum level of 92.7+4.7 % inhibition on ionophore A23187 
induced histamine release at 6x10.4 ^ (pig. 4.19) while SITS produced the 
maximum level of 95.6±1.0 % inhibition at 10'^  M (Fig. 4.20 & Table 4.1) when 
cells were activated without prior incubation with these blockers. Under the same 
condition, the inhibition attained to a maximum of nearly 100 % inhibition at 5x10"^ 
M N P P B and 2.5x10'^ M flufenamic acid which were the highest concentration used 
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for both preincubation times (Fig. 4.21 & Fig. 4.23). For DPC, its maximum effect 
was not as high as the others. It showed only 54.5±10.2 % maximum inhibition at 
2x10.4 M D P C (Fig. 4.22 & Table 4.1). As in the case with other secretagogues, 
IAA-94 was the only blocker having marginal effect on the histamine release 
induced by ionophore A23187 for both incubation times and the maximum inhibition 
ofIAA-94 on ionophore A23187 induced histamine release was only 15.1土5.8 % and 
17.4± 8.6 % for 0 and 10 minutes preincubation respectively (Table 4.1 & Fig. 4.24). 
Turning to the IC50 values of these blockers on histamine release induced by calcium 
ionophore A23187, N P P B was once again the most potent one among the six and its 
IC50 values were 2.5xl0_) M and 10'^  M for 0 and 10 minutes preincubation 
respectively (Table 4.2). Also, IAA-94 still showed the least potency. From table 
4.2, order of potency was N P P B > Flufenamic acid > DIDS > SITS > D P C and 
N P P B > Flufenamic acid > DIDS > D P C > SITS for 0 and 10 minutes preincubations 
respectively. 
4.3.4, Effects ofDSCG and the test blockers on thapsigargin induced histamine 
release from rat peritoneal mast cells 
D S C G once again had no effect on the histamine release induced by thapsigargin for 
both 0 and 10 minutes preincubation times (Fig. 4.25). In contrast, all the test 
blockers except IAA-94 showed a dose dependent inhibition ofthapsigargin induced 
histamine release for the two preincubation times. Besides, the inhibitory response 
was significantly increased when cells were preincubated with these blockers for 10 
minutes. In the case of DIDS, significant inhibition was initially observed at 3x10'^ ' 
M，and maximum inhibition of around 100 % was achieved at 3x10"^ M (Fig. 4.26). 
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Significant inhibition was only observed at 10"^  M and increased to 98.1±1.0 % 
inhibition at 10'^  M when cells were preincubated with SITS for 10 minutes (Fig. 
4.27). Flufenamic acid is the other blocker showing a near 100 % maximum 
inhibition at its highest concentration tested of 2.5xl0^ M in either 0 or 10 minutes 
preincubation time (Fig. 4.30). The dose inhibitory response curves for both N P P B 
and D P C showed a similar pattern with that of SITS. However, only a maximum 
level of 78.0±2.1 % inhibition and 49.3±6.1 % inhibition was observed in 5xl0'' M 
N P P B and 2x10"^ M D P C respectively (Fig. 4.28, Fig. 4.29 & Table 4.1). Even after 
10 minutes preincubation with IAA-94, the maximum inhibitory response was less 
than 20 % inhibition at the highest concentration used (Fig. 4.31). 
Similar to the observation in anti-IgE and calcium ionophore A23187, N P P B was the 
most potent blocker on histamine release induced by thapsigargin in either 0 or 10 
minutes preincubation time. Its IC50 values were 6x10'^ M and 2.5x10'^ M for 0 and 
10 minutes preincubation respectively on thapsigargin induced histamine release 
(Table 4.2). Moreover, as in the case with other secretagogues, IAA-94 was the least 
potent one which showed the maximum level of 2.6±1.6 % and 19.7+2.0 % 
inhibition for 0 and 10 minutes preincubation respectively (Table 4.1). From table 
4.2, order of potency was N P P B > Flufenamic acid > DIDS > D P C > SITS for both 0 
and 10 minutes preincubations respectively. 
4.3.5. Effects ofthe test blockers on Triton-X 100 induced histamine releasefrom 
rat peritoneal mast cells 
The triton-X 100 induced histamine release after 0 and 10 minutes preincubation was 
39.3±1.5 % and 32.6±3.4 % respectively. In general, D S C G demonstrated no effects 
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011 the triton-X 100 induced histamine release. Cells which were preincubated with 
DIDS, SITS and flufenamic acid for 0 or 10 minutes showed substantial potentiation 
of histamine release induced by triton-X 100. At the maximum concentration tested, 
10-3 M DIDS, 10-3 M SITS and 2.5xlO_4 M flufenamic acid increased the triton-X 
100 induced histamine release to 86.5±1.9 %, 60.3±2.2 % and 85.3±2.7 % 
respectively when the cells were activated without prior incubation with these 
blockers (Fig. 4.32, Fig. 4.33 & Fig. 4.36). Under the same condition, triton-X 100 
induced histamine release was slightly increased but not significantly potentiated by 
NPPB, D P C and IAA-94 (Fig. 4.34, Fig. 4.35 & Fig. 4.37). DIDS and flufenamic 
acid dose dependently potentiated triton-X 100 induced histamine release while there 
were no obvious dose dependent relationship observed with the remaining C1" 
channel blockers. 
4.3.6. Effects of DSCG and the test blockers on immunologically and non-
immunologically induced ^CVz :+ uptake 
In order to evaluate if the inhibitory effects of the tested compounds are related to the 
modulations of calcium influx, their effects on immunologically and non-
immunologically induced ^ ^ a uptake were studied. Only the top concentration of 
each blocker was tested due to the large number of cells required. A 0 minutes 
preincubation with DSCG, DIDS, NPPB, D P C or flufenamic acid was able to 
significantly inhibit the anti-IgE induced ^ ^ a uptake. Whereas after 10 minutes 
preincubation, only DIDS and IAA-94 showed significant inhibitory effect on the 
anti-IgE induced 4)Ca uptake (Fig. 4.38). For non-immunologically induced ^ ^ a 
uptake, with the exception of DPC, all the test compounds including D S C G were 
able to significantly inhibit the compound 48/80 induced ^ ^ a uptake without 
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preincubation. However, following a 10 minutes preincubation, N P P B and 
flufenamic acid had no significant inhibitory effect on ^ ^ a uptake (Fig. 4.39). 
Either a 0 or 10 minutes preincubation with D S C G was found to have no effect on 
the ionophore A23187 induced ^^Ca uptake. However, chloride channel blockers 
DIDS, SITS, N P P B and D P C showed a significantly inhibitory effect on ^ 'Ca uptake 
for 0 minutes preincubation, whereas after 10 minutes preincubation, only N P P B or 
IAA-94 was able to significantly inhibit the ionophore A23187 induced ^ ^ a uptake 
(Fig. 4.40). 
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Table 4.1. Summary of the maximum inhibition produced by D S C G and the 
blockers on histamine release induced by different secretagogues after 0 and 10 
minutes preincubations. 
Preincubation Anti-IgE Compound Ionophore Thapsigargin 
(min) 48/80 A23187 
D S C G 0 43.3+6.6 39.6+4.4 -0.01+2.1 5.4+5.3 
(10'%) 10 -5.01+3.4 28.8+2.4 -0.2+7.7 4.1+2.3 
• ~ — — —~ • 
DIDS 0 111.1+4.6 104.6+1.1 89.2+5.8 68.4+4.6~~ 
~ ~ ~ " — - _ 
(10-½) 10 104.6+7.6 108.6+3.0 86.6+5.9 101.9+1.6 
~ " —• — ^ _ 
SITS 0 75.2+4.3 84.1+2.4 95.6+1.0 31.7+2.6~~ 
(10"M) 10 104.6+7.0 95.2土5.6 86.1土3.2 98.1 + 1.0 
M a x i m u m NPPB 0 107.8+4.7 49.2+6.3 87.0+3.3 59.3+4.9 
i n h i b i t i o n ( 5 x i o - 5 M ) 1 0 8 3 . 0 + 1 0 . 0 3 1 . 9 + 7 . 7 9 8 . 3 + 6 . 4 7 8 . 0 + 2 . 1 
(%) — _ — — 
DPC 0 44.1+9.3 2.4+9.3 54.5+10.2 13.2+2.0""" 
(2xlO''M) 10 37.4+5.2 6.2+6.7 57.2+10.5 49.3+6.1 
•^~ — — - ^ 
Flufenamic 0 91.0+5.2 26.0+3.2 90.3+2.2 91.3+3.1 
acid 10 98.7+7.8 68.3+5.6 95.5+5.1 95.2+1.3 
~ * — — _>• 
(2.5xlQ-V) 
IAA-94 0 8.6+8.8 24.6+5.7 15.1+5.8 2.6±1.6 
(2.5xlO''M) 10 42.2土6.1 11.7土6.2 17.4+8.6 19.7+2.0 
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Table 4.2. Summary of the IC50 of D S C G and the blockers on histamine release 
induced by different secretagogues after 0 and 10 minutes preincubations. 
Preincubation Anti-IgE Compound Ionophore Thapsigargin 
(min) 48/80 A23187 
DSCG 0 >10"" >io'" >10"" 〉icr 
10 >10_4 >10_4 >10_4 >10_4 
DIDS 0 8.5xl0_) 1.5xlO_) 7^iW 8jdT^ 
10 7.5x10-5 1.5xlO_5 lxlO'4 lxlO_4 
"^TTS 0 7 x W 6.5x10" M F ^ > W 
10 lxlO_4 3.5xlO_4 2x10-4 5x10-4 
IC50 NPPB 0 b ^ 6^dF 2.5xl0-) 6 ^ 
(M) 10 3x10-5 >6x10-5 ixlO_5 2.5x10-5 
" D ^ 0 >3x10-^ >3x10-4 2 ^ ^ >3x10— 
10 >3x10—4 >3x10—4 1x10-4 3x10-4 
Flufenamic acid 0 6.5xl0_) >2.5x10-^ 6 ? ^ 1.5x10"^  
10 8.5xlO_5 3x10-4 8.5x10-5 9xl0"' 
IAA-94 0 >3x10-^ >3x10-4 >3x10— >3x10'^ 
10 >3x10—4 >3x10—4 >3x10—4 >3x10-4 
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Table 4.3. Inhibition effect ofDSCG, NPPB, DIDS and SITS on rat peritoneal mast 
cell activation by compound 48/80 in different no preincubation (0 min 
preincubation) protocols. In protocol 1, purified mast cells were added to test tubes 
containing both compound 48/80 and the test compound whereas both purified mast 
cells and compound 48/80 were added simultaneously to test tubes containing only 
the test compound in protocol 2. The corresponding anti-IgE experiment is included 
for comparison. Theophylline was also included for control. The compound 48/80 
and anti-IgE induced histamine release are 51.8±4.1% and31.3±4.7o/o respectively. 
Percentage inhibition of histamine 
release using different protocols 
Protocol 1 Protocol 2 Protocol 1 Protocol 2 
Compound 48/80 Compound 48/80 Anti-IgE added Anti-IgE added 
added before added with cells before with cells 
(n=8-ll) (n=8-ll) (n=4) (n=4) 
Theophylline 89.5+5.0 78.7+2.9 100.0±1.6 100.0+3.2 
(5xlO"^M) 
D S C G 56.3±6.8 27.5±3.2 69.5±3.5 67.9±3.8~~ 
(iO'V) * 
N P P B 43.1+6.0 13.1±2.9 42.1+4.0 37.3±4.7~~ 
(6xlO"^M) * 
N P P B 75.3±3.5 68.4土2.1 10L3±2.3 99.2±2.2~~ 
(5xlO-'M) 
DIDS 93.0±4.0 2.3±3.0 30.7±2.9 36.4+3.6~~ 
(3xlO-^M) * 
DIDS 107.7+3.3 97.4±1.4 83.7±1.6 81.5±4.2~" 
(3xlO-5M) * 
SITS 50.5±7.5 -1.8±1.5 25.8±3.3 32.2±4.0~~ 
(6xlO"'M) * 
SITS 107.9±2.5 50.5+4.8 66.3±2.6 64,8±4.6"~ 
(3xlQ-^M) * 
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Fig. 4.1. Chemical structure of disodium cromoglycate (DSCG) 
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Fig. 4.2. Chemical structures of chloride channel blockers: Indanyloxyacetic acid 94 
(IAA-94), 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS) and 4-acetamido-
4'-isothiocyanatostilbene-2,2'-disulfonic acid (SITS) 
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Fig. 4.3. Chemical structures of chloride channel blockers: 5-nitro-2-(3-
phenylpropylamino)-benzoic acid G^PPB), flufenamic acid and n-phenylanthranilic 
acid (DPC) 
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Fig. 4.4. Effects of D S C G on anti-IgE (1/200) induced histamine release from 
R P M C . Mast cells were preincubated for 0 or 10 minutes before the addition of anti-
IgE. Results are expressed as mean 土 S E M for n=4. * = p < 0.05, 0 min vs 10 min 
preincubation values. Spontaneous histamine release is 12.1±0.9o/o and 12.5±1.2o/o 
of total cellular histamine and the anti-IgE induced histamine release is 31.3±4.7o/o 
and 29.8+3.6% for 0 and 10 minutes preincubations respectively. 
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Fig. 4.5. Effects ofDEDS on anti-IgE (1/200) induced histamine release from R P M C . 
Mast cells were preincubated for 0 or 10 minutes before the addition of anti-IgE. 
Results are expressed as mean 土 S E M for n-8. * 二 p < 0.05, 0 min vs 10 min 
preincubation values. Spontaneous histamine release is 12.1+0.9% and 12.5+1.2% of 
total cellular histamine and the anti-IgE induced histamine release is 31.3±4.7o/o and 
29.8+3.6% for 0 and 10 minutes preincubations respectively. 
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Fig. 4.6. Effects of SITS on anti-IgE (1/200) induced histamine release from R P M C . 
Mast cells were preincubated for 0 or 10 minutes before the addition of anti-IgE. 
Results are expressed as mean 土 S E M for n=6. * = p < 0.05, 0 min vs 10 min 
preincubation values. Spontaneous histamine release is 12.1±0.9o/o and 12.5±1.2o/o of 
total cellular histamine and the anti-IgE induced histamine release is 31.3±4.7o/o and 
29.8+3.6% for 0 and 10 minutes preincubations respectively. 
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Fig. 4.7. Effects of N P P B on anti-IgE (1/200) induced histamine release from 
R P M C . Mast cells were preincubated for 0 or 10 minutes before the addition of anti-
IgE. Results are expressed as mean 土 S E M for n=5. * 二 p < 0.05, 0 min vs 10 min 
preincubation values. Spontaneous histamine release is 12.1±0.9o/o and 12.5±1.2o/o of 
total cellular histamine and the anti-IgE induced histamine release is 31.3±4.7o/o and 
29.8+3.6% for 0 and 10 minutes preincubations respectively. 
126 
100 n 
90 - ^ . 
• 0 min 




0 6 0 -
c 1 ,^  T 
ra 50 -
1 4。_ / 
g 30 - / / % 2。- / 
: b = U i r V ^ 
- 1 0」 I . , — , 
1 0-6 1 0-5 1 0-4 1 0-3 
D P C (M) 
Fig. 4.8. Effects o f D P C on anti-IgE (1/200) induced histamine release from R P M C . 
Mast cells were preincubated for 0 or 10 minutes before the addition of anti-IgE. 
Results are expressed as mean 土 S E M for n=5. Spontaneous histamine release is 
12.1土0.90/0 and 12.5±1.2o/o of total cellular histamine and the anti-IgE induced 
histamine release is 31.3±4.7o/o and 29.8±3.6o/o for 0 and 10 minutes preincubations 
respectively. 
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Fig. 4.9. Effects of Flufenamic acid on anti-IgE (1/200) induced histamine release 
from R P M C . Mast cells were preincubated for 0 or 10 minutes before the addition of 
anti-IgE. Results are expressed as mean 土 S E M for n=5, * = p < 0.05, 0 min vs 10 
min preincubation values. Spontaneous histamine release is 12.1±0.9% and 
12.5+1.2% of total cellular histamine and the anti-IgE induced histamine release is 
31.3+4.7% and 29.8±3.6o/o for 0 and 10 minutes preincubations respectively. 
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Fig. 4.10. Effects of IAA-94 on anti-IgE (1/200) induced histamine release from 
R P M C . Mast cells were preincubated for 0 or 10 minutes before the addition ofanti-
IgE- Results are expressed as mean 土 S E M for n=4. Spontaneous histamine release 
is 12.1+0.9% and 12.5+1.2% of total cellular histamine and the anti-IgE induced 
histamine release is 31.3+4.7% and 29.8±3.6o/o for 0 and 10 minutes preincubations 
respectively. 
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Fig. 4.11. Effects of D S C G on compound 48/80 (O.l^g/ml) induced histamine 
release from R P M C . Mast cells were preincubated for 0 or 10 minutes before the 
addition of compound 48/80. Results are expressed as mean 土 S E M for n=5. * = p < 
0.05, 0 min vs 10 min preincubation values. Spontaneous histamine release is 
11.8+1.1% and 13.2+1.5% of total cellular histamine and the compound 48/80 
induced histamine release is 51.8+4.1% and 40.8±2.4o/o for 0 and 10 minutes 
preincubations respectively. 
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Fig. 4.12. Effects ofDIDS on compound 48/80 (O.l^g/ml) induced histamine release 
from R P M C . Mast cells were preincubated for 0 or 10 minutes before the addition of 
compound 48/80. Results are expressed as mean 土 S E M for n=4. Spontaneous 
histamine release is 11.8±l.lo/o and 13.2±1.5o/o of total cellular histamine and the 
compound 48/80 induced histamine release is 51.8±4.1o/o and 40.8±2.4o/o for 0 and 
10 minutes preincubations respectively. 
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Fig. 4.13. Effects of SITS on compound 48/80 (O.l^g/ml) induced histamine release 
from R P M C . Mast cells were preincubated for 0 or 10 minutes before the addition of 
compound 48/80. Results are expressed as mean 土 S E M for n=4-8. * = p < 0.05, 0 
min vs 10 min preincubation values. Spontaneous histamine release is 11.8±l.lo/o 
and 13.2±1.5o/o of total cellular histamine and the compound 48/80 induced 
histamine release is 51.8+4.1% and 40.8±2.4o/o for 0 and 10 minutes preincubations 
respectively. 
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Fig. 4.14. Effects ofNPPB on compound 48/80 (O.l^ig/ml) induced histamine release 
from R P M C . Mast cells were preincubated for 0 or 10 minutes before the addition of 
compound 48/80. Results are expressed as mean 土 S E M for n=4-8. Spontaneous 
histamine release is 11.8±l.lo/o and 13.2±1.5o/o of total cellular histamine and the 
compound 48/80 induced histamine release is 51.8±4.1o/o and 40.8±2.4o/o for 0 and 
10 minutes preincubations respectively. 
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Fig. 4.15. Effects o f D P C on compound 48/80 (O.l^ig/ml) induced histamine release 
from R P M C . Mast cells were preincubated for 0 or 10 minutes before the addition of 
compound 48/80. Results are expressed as mean 土 S E M for n=5. Spontaneous 
histamine release is 11.8±L1% and 13.2+1.5% of total cellular histamine and the 
compound 48/80 induced histamine release is 51.8+4.1% and 40.8+2.4% for 0 and 
10 minutes preincubations respectively. 
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Fig. 4.16. Effects of Flufenamic acid on compound 48/80 (O.l^g/ml) induced 
histamine release from R P M C . Mast cells were preincubated for 0 or 10 minutes 
before the addition of compound 48/80. Results are expressed as mean 土 S E M for 
n=5. * = p < 0.05, 0 min vs 10 min preincubation values. Spontaneous histamine 
release is 11.8il.P/o and 13.2+1.5% of total cellular histamine and the compound 
48/80 induced histamine release is 51.8+4.1% and 40.8±2.4o/o for 0 and 10 minutes 
preincubations respectively. 
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Fig. 4.17. Effects of IAA-94 on compound 48/80 (O.lfj,g/ml) induced histamine 
release from R P M C . Mast cells were preincubated for 0 or 10 minutes before the 
addition of compound 48/80. Results are expressed as mean 土 S E M for n=5. 
Spontaneous histamine release is 11.8±l.lo/o and 13.2±1.5o/o of total cellular 
histamine and the compound 48/80 induced histamine release is 51.8+4.1% and 
40.8±2.4°/0 for 0 and 10 minutes preincubations respectively. 
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Fig. 4.18. Effects of D S C G on calcium ionophore A23187 (O.l^iM) induced 
histamine release from R P M C . Mast cells were preincubated for 0 or 10 minutes 
before the addition of calcium ionophore A23187. Results are expressed as mean 土 
S E M for n=4. Spontaneous histamine release is 13.0+0.4% and 13.9+1.3% of total 
cellular histamine and the calcium ionophore A23187 induced histamine release is 
55.7+5.3% and 27.2+2.7% for 0 and 10 minutes preincubations respectively. 
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Fig. 4.19. Effects ofDIDS on calcium ionophore A23187 (O.l^M) induced histamine 
release from R P M C . Mast cells were preincubated for 0 or 10 minutes before the 
addition of calcium ionophore A23187. Results are expressed as mean 土 S E M for 
n=5. Spontaneous histamine release is 13.0±0.4o/o and 13.9±1.3o/o of total cellular 
histamine and the calcium ionophore A23187 induced histamine release is 
55.7+5.3% and 27.2+2.7% for 0 and 10 minutes preincubations respectively. 
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Fig. 4.20. Effects of SITS on calcium ionophore A23187 (O.l^M) induced histamine 
release from R P M C . Mast cells were preincubated for 0 or 10 minutes before the 
addition of calcium ionophore A23187. Results are expressed as mean + S E M for 
n=5-7. * = p < 0.05, 0 min vs 10 min preincubation values. Spontaneous histamine 
release is 13.0±0.4o/o and 13.9+1.3% of total cellular histamine and the calcium 
ionophore A23187 induced histamine release is 55.7+5.3% and 27.2+2.7% for 0 and 
10 minutes preincubations respectively. 
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Fig. 4.21. Effects of N P P B on calcium ionophore A23187 (O.l^iM) induced 
histamine release from R P M C . Mast cells were preincubated for 0 or 10 minutes 
before the addition of calcium ionophore A23187. Results are expressed as mean 土 
S E M for n=5-7. Spontaneous histamine release is 13.0+0.4% and 13.9+1.3% of total 
cellular histamine and the calcium ionophore A23187 induced histamine release is 
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Fig. 4.22. Effects o f D P C on calcium ionophore A23187 (O.l^M) induced histamine 
release from R P M C . Mast cells were preincubated for 0 or 10 minutes before the 
addition of calcium ionophore A23187. Results are expressed as mean 土 S E M for 
n=5. Spontaneous histamine release is 13.0±0.4o/o and 13.9±1.3o/o of total cellular 
histamine and the calcium ionophore A23187 induced histamine release is 
55.7+5.3% and 27.2+2.7% for 0 and 10 minutes preincubations respectively. 
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Fig. 4.23. Effects ofFlufenamic acid on calcium ionophore A23187 (O.lp,M) induced 
histamine release from R P M C . Mast cells were preincubated for 0 or 10 minutes 
before the addition of calcium ionophore A23187. Results are expressed as mean 土 
S E M for n=4-6. * = p < 0.05, 0 min vs 10 min preincubation values. Spontaneous 
histamine release is 13.0±0.4o/o and 13.9±1.3o/o of total cellular histamine and the 
calcium ionophore A23187 induced histamine release is 55.7+5.3% and 27.2+2.7% 
for 0 and 10 minutes preincubations respectively. 
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Fig. 4.24. Effects of IAA-94 on calcium ionophore A23187 (O.l^M) induced 
histamine release from R P M C . Mast cells were preincubated for 0 or 10 minutes 
before the addition of calcium ionophore A23187. Results are expressed as mean 土 
S E M for n=5. Spontaneous histamine release is 13.0±0.4% and 13.9±1.3o/o of total 
cellular histamine and the calcium ionophore A23187 induced histamine release is 
55.7+5.3% and 27.2±2.7o/o for 0 and 10 minutes preincubations respectively. 
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Fig. 4.25. Effects of D S C G on thapsigargin (O.Ol^M) induced histamine release 
from R P M C . Mast cells were preincubated for 0 or 10 minutes before the addition of 
thapsigargin. Results are expressed as mean 土 S E M for n=4. Spontaneous 
histamine release is 13.9±1.4o/o and 13.3+0.7% of total cellular histamine and the 
thapsigargin induced histamine release is 53.6±l.lo/o and 48.3±1.5o/o for 0 and 10 
minutes preincubations respectively. 
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Fig. 4.26. Effects ofDIDS on thapsigargin (O.Ol^iM) induced histamine release from 
R P M C . Mast cells were preincubated for 0 or 10 minutes before the addition of 
thapsigargin. Results are expressed as mean 土 S E M for n=5. * = p < 0.05, 0 min vs 
10 min preincubation values. Spontaneous histamine release is 13.9±1.4o/o and 
13.3土0.70/0 of total cellular histamine and the thapsigargin induced histamine release 
is 53.6±l.lo/o and 48.3±1.5o/o for 0 and 10 minutes preincubations respectively. 
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Fig. 4.27. Effects of SITS on thapsigargin (O.Ol^M) induced histamine release from 
R P M C . Mast cells were preincubated for 0 or 10 minutes before the addition of 
thapsigargin. Results are expressed as mean 土 S E M for n=5. * = p < 0.05, 0 min vs 
10 min preincubation values. Spontaneous histamine release is 13.9±1.4% and 
13.3土0.70/0 of total cellular histamine and the thapsigargin induced histamine release 
is 53.6±l.lo/o and 48.3±1.5o/o for 0 and 10 minutes preincubations respectively. 
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Fig. 4.28. Effects o f N P P B on thapsigargin (O.Ol^M) induced histamine release from 
R P M C . Mast cells were preincubated for 0 or 10 minutes before the addition of 
thapsigargin. Results are expressed as mean 土 S E M for n=5. * = p < 0.05, 0 min vs 
10 min preincubation values. Spontaneous histamine release is 13.9±1.4o/o and 
13.3±0.7o/o of total cellular histamine and the thapsigargin induced histamine release 
is 53.6±l.lo/o and 48.3±1.5o/o for 0 and 10 minutes preincubations respectively. 
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Fig. 4.29. Effects of D P C on thapsigargin (O.Ol^M) induced histamine release from 
R P M C . Mast cells were preincubated for 0 or 10 minutes before the addition of 
thapsigargin. Results are expressed as mean 土 S E M for n=5. * 二 p < 0.05, 0 min vs 
10 min preincubation values. Spontaneous histamine release is 13.9±1.4o/o and 
13.3±0.7o/o of total cellular histamine and the thapsigargin induced histamine release 
is 53.6±1.1% and 48.3±1.5o/o for 0 and 10 minutes preincubations respectively. 
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Fig. 4.30. Effects of Flufenamic acid on thapsigargin (O.Ol^iM) induced histamine 
release from R P M C . Mast cells were preincubated for 0 or 10 minutes before the 
addition of thapsigargin. Results are expressed as mean 土 S E M for n=5. * = p < 
0.05, 0 min vs 10 min preincubation values. Spontaneous histamine release is 
13.9±1.4。/o and 13.3+0.7% of total cellular histamine and the thapsigargin induced 
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Fig. 4.31. Effects of IAA-94 on thapsigargin (O.Ol^M) induced histamine release 
from R P M C . Mast cells were preincubated for 0 or 10 minutes before the addition of 
thapsigargin. Results are expressed as mean 土 S E M for n=5. * = p < 0.05, 0 min vs 
10 min preincubation values. Spontaneous histamine release is 13.9±1.4o/o and 
13.3土0.70/0 of total cellular histamine and the thapsigargin induced histamine release 
is 53.6±l.lo/o and 48.3±1.5o/o for 0 and 10 minutes preincubations respectively. 
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Fig. 4.32. Effects o f D I D S on triton-X 100 (0.045|j.l/ml) induced histamine release 
from R P M C . Mast cells were preincubated for 0 or 10 minutes before the addition of 
triton-X 100. Results are expressed as mean 土 S E M for n=4. * = p < 0.05 against the 
triton-X 100 induced histamine release. Spontaneous histamine release is 11.3j:l.lo/o 
and 14.9土2.4。/0 of total cellular histamine and the triton-X 100 induced histamine 
release is 39.3土1.50/0 and 32.6±3.4o/o for 0 and 10 minutes preincubations 
respectively. 
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Fig. 4.33. Effects of SITS on triton-X 100 (0.045^il/ml) induced histamine release 
from R P M C . Mast cells were preincubated for 0 or 10 minutes before the addition of 
triton-X 100. Results are expressed as mean 土 S E M for n=4. * 二 p < 0.05 against the 
triton-X 100 induced histamine release. Spontaneous histamine release is 11.3±l.lo/o 
and 14.9+2.4% of total cellular histamine and the triton-X 100 induced histamine 
release is 39.3±1.5o/o and 32.6±3.4o/o for 0 and 10 minutes preincubations 
respectively. 
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Fig. 4.34. Effects of N P P B on triton-X 100 (0.045^1/ml) induced histamine release 
from R P M C . Mast cells were preincubated for 0 or 10 minutes before the addition of 
triton-X 100. Results are expressed as mean 土 S E M for n=4. * = p < 0.05 against the 
triton-X 100 induced histamine release. Spontaneous histamine release is 11.3±l.lo/o 
and 14.9±2.4o/o of total cellular histamine and the triton-X 100 induced histamine 
release is 39.3+1.5% and 32.6+3.4% for 0 and 10 minutes preincubations 
respectively. 
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Fig. 4.35. Effects o f D P C on triton-X 100 (0.045^1/ml) induced histamine release 
from R P M C . Mast cells were preincubated for 0 or 10 minutes before the addition of 
triton-X 100. Results are expressed as mean 土 S E M for n=4. Spontaneous histamine 
release is 11.3±l.lo/o and 14.9±2.4% of total cellular histamine and the triton-X 100 
induced histamine release is 39.3±1.5o/o and 32.6+3.4% for 0 and 10 minutes 
preincubations respectively. 
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Fig. 4.36. Effects of Flufenamic acid on triton-X 100 (0.045^1/ml) induced histamine 
release from R P M C . Mast cells were preincubated for 0 or 10 minutes before the 
addition of triton-X 100. Results are expressed as mean 土 S E M for n=4. * = p < 0.05 
against the triton-X 100 induced histamine release. Spontaneous histamine release is 
11.3±l.P/o and 14.9±2.4% of total cellular histamine and the triton-X 100 induced 
histamine release is 39.3±1.5o/o and 32.6±3.4o/o for 0 and 10 minutes preincubations 
respectively. 
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Fig. 4.37. Effects ofIAA-94 on triton-X 100 (0.045^il/ml) induced histamine release 
from R P M C . Mast cells were preincubated for 0 or 10 minutes before the addition of 
triton-X 100. Results are expressed as mean 土 S E M for n=4. Spontaneous histamine 
release is 11.3±l.lo/o and 14.9+2.4% of total cellular histamine and the triton-X 100 
induced histamine release is 39.3±1.5o/o and 32.6±3.4o/o for 0 and 10 minutes 
preincubations respectively. 
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Fig. 4.38. Effects of 0 and 10 minutes preincubation with D S C G and the test 
blockers on anti-IgE induced "^^ Ca uptake into rat peritoneal mast cells. The 
spontaneous ^"Ca uptake were 388.3+48.7 and 345.6+30.4 dpm/lCP cells and anti-
IgE induced '''Ca uptake were 2150.6±260.4 and 1425.3土215.3 dpm/10' cells for 0 
and 10 minutes preincubation respectively. Results are expressed as mean : S E M for 
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Fig. 4.39. Effects of 0 and 10 minutes preincubation with D S C G and the test blockers 
on compound 48/80 induced ^^Ca uptake into rat peritoneal mast cells. The 
spontaneous ^ ^ a uptake were 236.9±37.1 and 227.4±42.1 dpm/10^ cells and 
compound 48/80 induced ^ ^ a uptake were 2785.1+282.9 and 1512.1±372.1 
dpm/10^ cells for 0 and 10 minutes preincubation respectively. Results are expressed 
as mean 土 S E M for n=4. * = p < 0.05 compared to control. 
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Fig. 4.40. Effects of 0 and 10 minutes preincubation with D S C G and the test blockers 
on calcium ionophore A23187 induced ^)Ca uptake into rat peritoneal mast cells. 
The spontaneous ^'Ca uptake were 553.1土99.9 and 665.7土92.1 dpm/10' cells and 
calcium ionophore A23187 induced ^'Ca uptake were 4732.6+600.8 and 
4523.7+625.4 dpm/10' cells for 0 and 10 minutes preincubation respectively. Results 
are expressed as mean 土 SEIvI for n=4. * = p < 0.05 compared to control. 
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4.4. Discussion 
In order to further evaluate if an inward movement of chloride through chloride 
channels may be part of the mechanisms controlling antigen-stimulated histamine 
secretion from rat peritoneal mast cells as previously suggested (Friis et al., 1994), 
the effects of chloride channel blockers on antigen-stimulated mast cell histamine 
secretion were investigated and compared with D S C G since it was suggested that the 
inhibiting effect of D S C G on mast cell might be due to blocking of chloride 
channels. The effects of the chloride channel blockers on non-immunologically-
stimulated histamine release induced by secretagogues such as compound 48/80, 
calcium ionophore A23187, thapsigargin and triton-X 100 were also studied for 
comparison. 
It is obvious from our present study that even if all the test compounds eventually 
affected C1" influx and subsequently Ca�+ influx, D S C G and the chloride channel 
blockers were acting through different mechanisms. First of all, the inhibiting effects 
o f D S C G on immunological activation of mast cells demonstrated tachyphylaxis, i.e. 
rapid loss of activity following incubation with cells whereas the inhibitory effects of 
the chloride channel blockers in general were enhanced after 10 minutes 
preincubation with cells. Secondly, the secretagogue specificity pattem of D S C G is 
different from that demonstrated by the chloride channel blockers. As previously 
reported by Stenton & Lau (1996), the current study confirmed that D S C G could 
effectively inhibit anti-IgE and compound 48/80 induced histamine release from rat 
peritoneal mast cells and hence suggested that it may be acting at a common site in 
the activation pathways of the two secretagogues. Besides, the lack of inhibition to 
calcium ionophore A23187 induced histamine release suggested that D S C G may 
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interfere with the opening of calcium channels commonly activated by both anti-IgE 
and compound 48/80 since the influx of extracellular calcium was required by both 
secretagogues for the m a x i m u m level of histamine release from mast cells. 
Furthermore, D S C G had no effect on mast cells activated by thapsigargin suggesting 
that it may not have effects on the depletion operated calcium channels. The exact 
mechanism of the mast cell stabilizing action for D S C G still remains unknown. It 
has previously been postulated that D S C G might stabilise mast cells through 
interaction with plasma membrane binding sites (Mazurek et al., 1984) and 
subsequently activated an endogenous physiological secretion control mechanism 
(Correia et al., 1996) which reduces the influx of calcium followed by the 
suppression of exocytosis. More recent studies suggested the possibility that D S C G 
m a y indirectly prevent the influx of calcium by blocking chloride channels fNorris & 
Alton, 1996). It was reported that sodium cromoglycate blocked intermediate 
conductance chloride channels in patches of cultured mucosal-like mast cell (IC50 
15^M), when applied to the cytoplasmic side of the inside-out patches (Romanin et 
al., 1991; Reinsprecht et al, 1992). 
The inhibition of immunologically induced histamine release from rat peritoneal 
mast cells by frusemide is believed to be through the same mechanism as D S C G 
(Friis et al., 1994; Redrup et aL, 1997; Stenton & Lau, 1998). It was found that 
similar to the removal of chloride ions from extracellular media, frusemide reduced 
the rate of anti-IgE-stimulated chloride influx at a relatively high concentration of 
700 ^ M . The inhibition of chloride influx mediated by D S C G and frusemide is 
believed to be due only to the inhibition of chloride channels since immunologically 
induced histamine release and chloride uptake was not reduced by the more potent 
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Na+/K+/ 2Cr contransporter inhibitor bumetamide (Redrup et al., 1997). The 
observation that D S C G could inhibit ^ ^Ca^^ influx in immunologically activated rat 
mast cells in the current study can be correlated to the reduced chloride influx 
observed in earlier studies with fmsemide (providing that frusemide shares the same 
mechanism of action of DSCG). However, the previously reported failure of 
frusemide in reducing the C1" influx induced by compound 48/80 does not correlate 
with the reduced compound 48/80 induced ^ ^a^^ influx mediated by D S C G . 
It is still speculative if D S C G directly inhibits chloride channels and subsequently 
prevents the influx of calcium in the mast cells. Earlier studies had identified a 
D S C G binding protein which demonstrates characteristics of a calcium channel and 
hence suggesting a direct effect o f D S C G on calcium channel (Mazurek et aL, 1980 
& 1984). Mechanisms other than direct inhibition of C1' channel may also be 
involved. In fact, it has been demonstrated that D S C G induced phosphorylation of a 
78 kDa protein which is believed to be the endogenous termination signal for 
immunologic activation (Correia et al., 1996; Cox et al., 1998; Martin et al., 1995). 
The importance of the phosphorylation process is high-lighted by the observation 
that dephosphorylation of this protein paralleled the onset of tachyphylaxis in rat 
mast cells. Although this 78 kDa protein has recently been identified as the specific 
P K C substrate, the M A R C K S protein (Correia et al., 1996), the exact mechanism of 
actions for D S C G still remained to be resolved. 
Since systematic studies on a wide range of chloride channel blockers on mast cells 
have not been reported, the chloride channel blockers chosen for the current study 
were based mainly on the paper of Phipps et al (1996) who investigated the 
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inhibition ofT lymphocyte activation and signalling by chloride channel blockers. It 
has been demonstrated that T lymphocytes and mast cells share various c o m m o n 
activation pathways such as tyrosine kinase activation, increase in intracellular 
calcium and the opening of chloride channels (Kuno & Gardner, 1987; Siraganian, 
1993; White et al,, 1984). A m o n g 13 potential chloride channel blockers tested 
(Phipps et al., 1996), dose dependent inhibition of C1' current in normal, non-
transformed human T lymphocytes was achieved by externally applied flufenamic 
acid, NPPB, IAA-94, DIDS and SITS. 4 ofthese C1" channel blockers were further 
demonstrated to dose-dependently inhibit small-conductance C1' channels and phyto-
haemagglutamin induced lymphocyte proliferation (Phipps et al., 1996). Their order 
of potency was N P P B > DIDS > flufenamic acid » IAA-94. 
In addition to confirming the dose dependent inhibition of immunological activation 
of rat peritoneal mast cells by DIDS and N P P B within the concentration ranges 
previously reported, the current study has extended similar observations to 
flufenamic acid, SITS and DPC. IAA-94 was relatively ineffective. It was initially 
anticipated that similar to D S C G , the chloride channel blockers may demonstrate 
particular pattern of secretagogue selectivity among the four mast cells secretagogues 
which mobilise different pools of calcium. However, these compounds were almost 
equipotent against histamine release induced by all the four secretagogues. With 
reference to results obtained in the chloride depletion experiments, the secretagogue 
selectivity demonstrated by D S C G may be due to the partial reduction of C1" influx 
as observed in the isethionate buffer whereas the lack of similar selectively by the C1" 
channel blockers may be due to a significant or total inhibition of C1" influx as 
observed in the gluconate buffer. Confirmation of such a speculation obviously will 
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require further study correlating the histamine release inhibiting effects of these 
compound with the direct measurement of C1' influx. 
Since it was reported that compound 48/80 and ionophore A23187 induced histamine 
release were not associated with a corresponding increase in C1" uptake (Redrup et 
al,, 1997), the inhibition of histamine release induced by these secretagogues by the 
chloride channel blockers suggests that the blockers may have a rather non-specific 
mast cell stabilizing action not relating to inhibition of C1' influx. In fact, more 
recent studies have reported various non-chloride channel blocking effects associated 
with a number of putative chloride channel blockers. In a whole cell patch-clamp 
study on rat mucosal-type mast cells, N P P B ( I C 5 0 二 23 ^ M ) and D P C ( I C 5 0 = 190 
M-M) were reported to directly inhibit calcium current in addition to chloride channels 
(Reinsprecht et al,, 1995). Furthermore, NPPB, D P C and flufenamic acid have been 
found to effectively block not only C1' channels but also C1' exchangers, and non-
selective cation channels (Cabantchik & Greger, 1992). 
Moreover, the inhibitory effect ofDIDS on mast cell exocytosis was also believed to 
be not due to C1' channel blockade. Similar to our current study, Dietrich and Lindau 
(1994) observed that although DIDS could effectively inhibit secretion from 
compound 48/80 activated mast cells, substitution of extracellular chloride by 
glutamate has only very small effects. The chloride channel blockade independent 
inhibition of mast cells activation is further supported by Friis et al (1996) who 
reported that DIDS failed to affect antigen induced C1' uptake into rat peritoneal mast 
cells while histamine release was suppressed. As illustrated in table 4.3, such 
observation may be due to the interference of DIDS with cationic agonists such as 
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compound 48/80 rather than the exocytotic process. Similar observations had also 
been reported in other systems. For example, although stilbene disulfonic acid anion 
channel blockers have been reported to inhibit exocytosis of platelets (Pollard et al,, 
1977) and neutrophils (Korchak et cd., 1980), it was suggested that these compounds 
may interfere with the agonist rather than the exocytotic response in the case of 
thrombin stimulation of platelets (Vostal et aL, 1989). This interaction with 
compound 48/80 has also been extended to D S C G and N P P B in the current study. 
Although we had minimised the influence by adding the cells at the same time as 
compound 48/80 to tubes containing these compounds, how much of the final 
observation was affected by this interaction is unknown. 
Our observation that DIDS, flufenamic acid and SITS potentiated triton-X 100 
induced histamine release further suggested that these compounds may inhibit mast 
cell exocytosis via a non-specific membrane stabilising effect. It has been suggested 
that surface active compounds such as detergents and anaesthetics are capable of 
expanding biological membranes (Seeman, 1972). Over-expansion of cellular 
membranes by high concentrations of a surface active compound then causes 
disruption of the cell whereas expansion caused by sublytic concentrations of the 
same compound may protect against osmotic, mechanical or acid lysis. Hence 
DIDS, flufenamic acid and SITS may stabilise mast cell by a surface action similar to 
sublytic concentrations of surface active compounds. However, the same surface 
activities may aggravate the volume expansion induced by triton-X 100 and hence 
cause potentiation of the detergent induced lysis of mast cells as indicated by the 
increased histamine release. The remaining blockers only marginally elevated triton-
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X 100 induced histamine release and hence may not have significant non-specific 
membrane active effects. 
With the exception of compound 48/80 and triton-X 100 induced histamine release 
from rat peritoneal mast cells, the selected chloride channel blockers demonstrated 
similar rank order of potency as previously reported in the T-lymphocyte study of 
Phipps et al (1996), i.e. N P P B >DIDS > flufenamic acid » IAA-94. In the 
lymphocyte study, effects of these compounds on early (Ca�+ signalling, protein 
tyrosine phosphorylation) and late (interleukin-2 dependent) events in T lymphocyte 
were compared in order to further investigate the mechanisms of actions of these 
chloride channel blockers. Since both early and late phases of T-cell proliferation 
were found to be inhibited by the C1" channel blockers, it was suggested that Ca=+ 
signalling defects was not the main mechanism of action of these compounds. 
Instead, the authors had postulated that C1' channel in T-cells may allow 
neutralisation of H+ produced during T-cell proliferation and activation by providing 
a pathway for passive H C O s V O H ' entry. Closing of these C1' channels by the 
chloride channel blockers then leads to cytosolic acidification in lymphocytes and 
prevent tyrosine kinase activation and lymphocyte proliferation. Hence, chloride 
channel blockers may affect mast cell activation through such a chloride channel 
related but C1" influx independent mechanism. 
In order to gain further insight into the mechanisms of actions of these blockers, we 
attempted to correlate the effects of the chloride channel blockers on histamine 
release to the influx of extracellular ^ 'Ca"^. D S C G has been known to inhibit mast 
cell activation by inhibiting the influx of extracellular calcium (Mazurek et al., 1980; 
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Martin et al., 1995). Here, it was once again confirmed that D S C G inhibited the 
influx of extracellular ^^Cd^^ induced by anti-IgE and compound 48/80, but not 
ionophore A23187. These results were very similar to findings in immunological 
and non-immunological histamine release from rat peritoneal mast cells. Moreover, 
the lost of inhibitory effect following 10 minutes preincubation correlates with a 
reduction of ^ ^Ca^^ influx blocking potency. However, the situation observed in the 
blockers was totally different and inconsistent. In general, although most of the 
blockers demonstrated comparable potency in inhibiting histamine release induced 
by anti-IgE, compound 48/80 and ionophore A23187 with either 0 or 10 minutes 
preincubation, they were generally more effective in inhibiting the influx of 
extracellular ^ ^C^^ with 0 minutes preincubation. Inhibition of ^ ^Ca^^ influx was 
either reduced or lost after the cells were preincubated with various chloride channel 
blockers for 10 minutes. Moreover, IAA-94, showing the lack of inhibition of 
histamine release induced by the three secretagogues, was found to somehow inhibit 
the influx of extracellular ^ ^Ca^^. Such inconsistency may be due to the non-specific 
activities of single high concentrations of blockers employed in the current study. 
Further studies such as full dose-dependent relationship will be required to provide a 
more complete picture. 
4.5. Conclusion 
Electrophysiological studies by Matthews and co-workers (1989a) has identified a 
small-conductance chloride channel which was activated in rat peritoneal mast cells 
when the cells were stimulated with externally applied secretagogues such as 
compound 48/80, antigen and substance P. Consequently the chloride influx through 
the chloride channels caused a negative membrane potential which was suggested to 
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be a driving force for the entry of external calcium. In the current study, antigen-
stimulated histamine secretion from rat peritoneal mast cells and the related 
intracellular calcium increase were inhibited when extracellular chloride was 
replaced by either isethionate or gluconate anions. Such observation further 
supported the hypothesis that chloride influx facilitates the increase in intracellular 
calcium required for the immunological activation of mast cells (Fig. 4.41). 
In contrast, removal of extracellular chloride had no effect on compound 48/80 
activated mast cells either for histamine release or the intracellular calcium increase. 
This observation agreed with previous patch clamp studies which showed that the 
activation of the chloride current was not essential for compound 48/80 stimulated 
exocytosis (Dietrich & Lindau, 1994). Hence, the involvement of G proteins which 
coupled directly to exocytosis in this activation may account for such observation 
(Fig.4.42). 
In addition, a change in the ionic compositions of the media by replacing C1' ions 
with isethionate and gluconate ions also affected the histamine release and 
intracellular calcium increase induced by calcium ionophores and thapsigargin. 
However, the complicated results produced could not be explained by simple 
correlation of chloride ion depletion to calcium influx suppression. Obviously, 
further experiments are required to clarify the relations between chloride ion and 
mast cell activation by these two types of secretagogues. On the other hand, the 
importance of replacing all the chloride ions was also highlighted when effects of the 
isethionate buffer were compared with the gluconate buffer. 
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Given the potential role of chloride influx in mast cell activation, the effects of a 
range of chloride channel blockers including DIDS, SITS, NPPB, DPC, IAA-94 and 
flufenamic acid were then investigated pharmacologically on histamine release and 
intracellular calcium increase from rat peritoneal mast cells. Although the chloride 
channel blockers in general inhibited histamine release from mast cells activated by 
non-cytotoxic secretagogues dose-dependently (5xlO"^ - 10'^  M), they did not 
demonstrate the tachyphylaxis and secretagogue selectivity o f D S C G . Hence even if 
D S C G interferes with mast cell activation by blocking the influx of chloride, it does 
so through a different mechanism from directly blocking the chloride channels. 
The exact mechanism of actions for the inhibitory effects of the chloride channel 
blockers was not investigated in the present study. It was only found that N P P B was 
most potent with I C 5 0 values around 10"^  M , whereas IAA-94 was almost ineffective. 
However, the lack of correlation between the inhibitory effects of blockers on 
histamine release and ^^Ca^^ influx together with the potentiation of triton-X 100 
induced histamine release suggest that non-specific mechanisms not involving 
chloride channel block may be involved. Further studies involving the concurrent 
2+ 
measurement of Ca and C1' influx over a full concentration range of more specific 
chloride channel blockers will be useful for understanding the relationship between 
the influxes of these two ions through membrane channels in mast cell activation. 
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Fig. 4.41. The proposed correlation between chloride influx and extracellular 
calcium influx on mast cell activation activated by antigen. The hyperpolarization 
driven calcium influx was essential to support antigen-stimulated mast cell 
degranulation. ER: Endoplasmic reticulum 
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Fig. 4.42. The proposed correlation between chloride influx and extracellular 
calcium influx on mast cell activation activated by compound 48/80. Compound 
48/80 can directly activate another G protein which is coupled directly to exocytosis. 
The delay in the initiation of calcium increase in chloride depleted buffers may be 
due to the reduced influx of chloride at the time of cell activation which renders the 
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